
#### HIV ARegistration

Data elements for this activity can be collected using the [HIV](Questionnaire-HIV.html)

|Id|Label|Description|Type|Profile Path|
|---|---|---|---|---|
|HIV.A.DE1|First name|Client's first or given name|string|[Observation.value[x]](StructureDefinition-hiv-a-de1.html)|
|HIV.A.DE10|National health ID|National health unique identifier assigned to the client, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-a-de10.html)|
|HIV.A.DE11|National programme ID|National programme unique identifier assigned to the client, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-a-de11.html)|
|HIV.A.DE12|National health insurance ID|National health insurance unique identifier assigned to the client, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-a-de12.html)|
|HIV.A.DE13|Country of birth|Country where the client was born|string|[Observation.value[x]](StructureDefinition-hiv-a-de13.html)|
|HIV.A.DE14|Date of birth|The client's date of birth (DOB) if known|string|[Observation.value[x]](StructureDefinition-hiv-a-de14.html)|
|HIV.A.DE15|Date of birth unknown|Is the client's DOB is unknown?|string|[Observation.value[x]](StructureDefinition-hiv-a-de15.html)|
|HIV.A.DE16|Estimated age|If DOB is unknown, enter the client's estimated age. Display client's age in number of years.|string|[Observation.value[x]](StructureDefinition-hiv-a-de16.html)|
|HIV.A.DE17|Age|Calculated age (number of years) of the client based on date of birth|string|[Observation.value[x]](StructureDefinition-hiv-a-de17.html)|
|HIV.A.DE18|Gender*|Gender of the client*|string|[Observation.value[x]](StructureDefinition-hiv-a-de18.html)|
|HIV.A.DE2|Family name|Client's family name or last name|string|[Observation.value[x]](StructureDefinition-hiv-a-de2.html)|
|HIV.A.DE24|Other (specify)|Additional category (please specify)|string|[Observation.value[x]](StructureDefinition-hiv-a-de24.html)|
|HIV.A.DE25|Sex|Sex of the client assigned at birth|string|[Observation.value[x]](StructureDefinition-hiv-a-de25.html)|
|HIV.A.DE29|Address|Client's home address or address which the client is consenting to disclose|string|[Observation.value[x]](StructureDefinition-hiv-a-de29.html)|
|HIV.A.DE3|Visit date|The date and time of the client's visit|string|[Observation.value[x]](StructureDefinition-hiv-a-de3.html)|
|HIV.A.DE30|Marital Status|Client's current marital status|string|[Observation.value[x]](StructureDefinition-hiv-a-de30.html)|
|HIV.A.DE4|Referral|If client was referred for care|string|[Observation.value[x]](StructureDefinition-hiv-a-de4.html)|
|HIV.A.DE42|Telephone number|Client's telephone number (a landline or a mobile phone number)|string|[Observation.value[x]](StructureDefinition-hiv-a-de42.html)|
|HIV.A.DE43|[Administrative Area]|This should be a context-specific list of administrative areas, such as villages, districts, etc. The purpose of this data element is to allow for grouping and flagging of client data to a particular facility's catchment area. This can be input into the system by the end user OR it can be automated in the database based on the end user's attributes.|string|[Observation.value[x]](StructureDefinition-hiv-a-de43.html)|
|HIV.A.DE44|Communication consent|Indication that client gave consent to be contacted|string|[Observation.value[x]](StructureDefinition-hiv-a-de44.html)|
|HIV.A.DE45|Reminder messages|Whether client wants to receive text or other messages as follow-up for HIV services|string|[Observation.value[x]](StructureDefinition-hiv-a-de45.html)|
|HIV.A.DE46|Communication preference(s)|How the client would like to receive family planning communications|string|[Observation.value[x]](StructureDefinition-hiv-a-de46.html)|
|HIV.A.DE49|Client's email|Client's primary email account where the client can be contacted|string|[Observation.value[x]](StructureDefinition-hiv-a-de49.html)|
|HIV.A.DE5|Referred by|How the client was referred|string|[Observation.value[x]](StructureDefinition-hiv-a-de5.html)|
|HIV.A.DE50|Alternate contact's name|Name of an alternate contact, which could be next of kin (e.g. partner, husband, mother, sibling, etc.). The alternate contact would be used in the case of an emergency situation.|string|[Observation.value[x]](StructureDefinition-hiv-a-de50.html)|
|HIV.A.DE51|Alternate contact's phone number|Phone number of the alternate contact|string|[Observation.value[x]](StructureDefinition-hiv-a-de51.html)|
|HIV.A.DE52|Alternate contact's address|Alternate contact's home address or address which the client is consenting to disclose|string|[Observation.value[x]](StructureDefinition-hiv-a-de52.html)|
|HIV.A.DE53|Alternate contact relationship|The alternate contact's relationship to the client (e.g. partner, husband, mother, sibling, etc.)|string|[Observation.value[x]](StructureDefinition-hiv-a-de53.html)|
|HIV.A.DE8|Unique identifier|Unique identifier generated for new clients or a universal ID, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-a-de8.html)|
|HIV.A.DE9|National ID|National unique identifier assigned to the client, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-a-de9.html)|
|HIV.B.DE1|Reason for visit|Reason for HIV testing services visit|string|[Observation.value[x]](StructureDefinition-hiv-b-de1.html)|
|HIV.B.DE102|Test result of HIV assay 3|The result of the third HIV assay in the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de102.html)|
|HIV.B.DE106|Test result of HIV assay 1 repeated|The result of the repeated first HIV assay in the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de106.html)|
|HIV.B.DE110|HIV test date|Date of the HIV test|string|[Observation.value[x]](StructureDefinition-hiv-b-de110.html)|
|HIV.B.DE111|HIV test result|The result from HIV testing after applying the testing algorithm|string|[Observation.value[x]](StructureDefinition-hiv-b-de111.html)|
|HIV.B.DE115|HIV status|HIV status reported after applying the national HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.|string|[Observation.value[x]](StructureDefinition-hiv-b-de115.html)|
|HIV.B.DE119|Date positive HIV test confirmed|Date patient received positive HIV test confirmation (with written documentation)|string|[Observation.value[x]](StructureDefinition-hiv-b-de119.html)|
|HIV.B.DE120|Site where positive HIV test confirmed|Name or identifier of health facility where HIV test was confirmed|string|[Observation.value[x]](StructureDefinition-hiv-b-de120.html)|
|HIV.B.DE121|Probable route of transmission*|Probable route(s) of transmission of HIV to client|string|[Observation.value[x]](StructureDefinition-hiv-b-de121.html)|
|HIV.B.DE129|Partner HIV test conducted|If the client does not know the HIV status of the client's partner(s), offer to test and add results here|string|[Observation.value[x]](StructureDefinition-hiv-b-de129.html)|
|HIV.B.DE13|Contact with and (suspected) exposure to HIV|When the client is reported to have had suspected exposure to HIV|string|[Observation.value[x]](StructureDefinition-hiv-b-de13.html)|
|HIV.B.DE130|Partner HIV test ordered|An HIV test for the client's partner has been ordered|string|[Observation.value[x]](StructureDefinition-hiv-b-de130.html)|
|HIV.B.DE131|Partner HIV test date|Date of client's partner's HIV test|string|[Observation.value[x]](StructureDefinition-hiv-b-de131.html)|
|HIV.B.DE132|Partner HIV test result|The HIV test result of the client's partner|string|[Observation.value[x]](StructureDefinition-hiv-b-de132.html)|
|HIV.B.DE136|Partner HIV status (confirmed)|The HIV status of a sexual or drug-injecting partner of the client, based on a confirmed test result|string|[Observation.value[x]](StructureDefinition-hiv-b-de136.html)|
|HIV.B.DE14|Date/time of suspected exposure to HIV|Date and time when the client had suspected exposure to HIV|string|[Observation.value[x]](StructureDefinition-hiv-b-de14.html)|
|HIV.B.DE140|Partner on ART|Partner of the client is on ART|string|[Observation.value[x]](StructureDefinition-hiv-b-de140.html)|
|HIV.B.DE141|Partner virally suppressed on ART|ART and virally suppression status of a partner of the client|string|[Observation.value[x]](StructureDefinition-hiv-b-de141.html)|
|HIV.B.DE142|Counselling provided|Whether counselling was provided to a client during the visit|string|[Observation.value[x]](StructureDefinition-hiv-b-de142.html)|
|HIV.B.DE149|Prevention services offered and referrals|Offer or refer to prevention services|string|[Observation.value[x]](StructureDefinition-hiv-b-de149.html)|
|HIV.B.DE15|Testing entry point|Whether testing is happening in the community or at a facility|string|[Observation.value[x]](StructureDefinition-hiv-b-de15.html)|
|HIV.B.DE158|Sexual and reproductive health integrated services|Offer or refer to sexual and reproductive health services|string|[Observation.value[x]](StructureDefinition-hiv-b-de158.html)|
|HIV.B.DE165|Offer other clinical services|Other clinical services offered or referrals given to the client|string|[Observation.value[x]](StructureDefinition-hiv-b-de165.html)|
|HIV.B.DE172|Other support services|Offer or refer for other support services|string|[Observation.value[x]](StructureDefinition-hiv-b-de172.html)|
|HIV.B.DE178|Clinical enquiry for intimate partner violence (IPV) done|Whether a clinical enquiry for intimate partner violence was conducted|string|[Observation.value[x]](StructureDefinition-hiv-b-de178.html)|
|HIV.B.DE179|Intimate partner violence enquiry results|Result of medical inquiry for intimate partner violence|string|[Observation.value[x]](StructureDefinition-hiv-b-de179.html)|
|HIV.B.DE18|Entry point for community-level testing|Specific point in the community where testing is happening|string|[Observation.value[x]](StructureDefinition-hiv-b-de18.html)|
|HIV.B.DE184|Other IPV result (specify)|Other intimate partner violence (IPV) result not described above (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de184.html)|
|HIV.B.DE185|Offered voluntary partner services|Whether the client was offered voluntary partner services or family services|string|[Observation.value[x]](StructureDefinition-hiv-b-de185.html)|
|HIV.B.DE186|Count of contacts or partners given for social network-based/partner services|The quantity of contacts or partners given by a client that accepts social network-based/partner services for follow-up|string|[Observation.value[x]](StructureDefinition-hiv-b-de186.html)|
|HIV.B.DE187|Offered social network-based/partner services|Whether the client was offered social network-based partner services|string|[Observation.value[x]](StructureDefinition-hiv-b-de187.html)|
|HIV.B.DE188|Accepted social network-based/partner services|Whether the client accepted social network-based partner services|string|[Observation.value[x]](StructureDefinition-hiv-b-de188.html)|
|HIV.B.DE189|Contact first name to offer social network-based/partner services|First name of each contact given by the client to offer social network-based/partner services|string|[Observation.value[x]](StructureDefinition-hiv-b-de189.html)|
|HIV.B.DE190|Contact last name to offer social network-based/partner services|Last or family name of each contact given by the client to offer social network-based/partner services|string|[Observation.value[x]](StructureDefinition-hiv-b-de190.html)|
|HIV.B.DE191|Type of follow-up appointment|Type of follow-up appointment for testing services|string|[Observation.value[x]](StructureDefinition-hiv-b-de191.html)|
|HIV.B.DE194|Other reason for the follow-up appointment (specify)|Other reason for the follow-up appointment (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de194.html)|
|HIV.B.DE195|Date/time of follow-up appointment|Date the patient is to return for monitoring, re-supply or any other reason|string|[Observation.value[x]](StructureDefinition-hiv-b-de195.html)|
|HIV.B.DE196|Recommended follow-up date|Date when follow-up is recommended based on follow up requirements|string|[Observation.value[x]](StructureDefinition-hiv-b-de196.html)|
|HIV.B.DE197|VMMC procedure|Whether a voluntary medical male circumcision procedure was performed|string|[Observation.value[x]](StructureDefinition-hiv-b-de197.html)|
|HIV.B.DE198|VMMC procedure date|Date on which a voluntary medical male circumcision procedure was performed|string|[Observation.value[x]](StructureDefinition-hiv-b-de198.html)|
|HIV.B.DE199|Adverse event reported from a VMMC|Whether an adverse event was reported associated with a voluntary medical male circumcision (VMMC) procedure|string|[Observation.value[x]](StructureDefinition-hiv-b-de199.html)|
|HIV.B.DE200|Serious adverse event|Complications from voluntary medical male circumcision (VMMC) procedure resulted in death or hospitalization within 30 days of the procedure or permanent disability|string|[Observation.value[x]](StructureDefinition-hiv-b-de200.html)|
|HIV.B.DE201|Adverse event severity|Severity of the adverse event associated with voluntary medical male circumcision (VMMC) procedure|string|[Observation.value[x]](StructureDefinition-hiv-b-de201.html)|
|HIV.B.DE202|Moderate|Severity of the adverse event associated with VMMC procedure was moderate|string|[Observation.value[x]](StructureDefinition-hiv-b-de202.html)|
|HIV.B.DE203|Severe|Severity of the adverse event associated with VMMC procedure was severe|string|[Observation.value[x]](StructureDefinition-hiv-b-de203.html)|
|HIV.B.DE204|Timing of adverse event|When the adverse event associated with VMMC procedure occurred|string|[Observation.value[x]](StructureDefinition-hiv-b-de204.html)|
|HIV.B.DE207|Type of adverse VMMC event|Type of adverse event associated with voluntary medical male circumcision (VMMC) procedure|string|[Observation.value[x]](StructureDefinition-hiv-b-de207.html)|
|HIV.B.DE22|Entry point for facility-level testing|Specific point where testing is happening at a facility|string|[Observation.value[x]](StructureDefinition-hiv-b-de22.html)|
|HIV.B.DE224|HIV retest prior to starting ART conducted|HIV retest prior to starting ART conducted|string|[Observation.value[x]](StructureDefinition-hiv-b-de224.html)|
|HIV.B.DE225|At elevated risk for HIV acquisition|Client is at elevated risk for HIV acquisition|string|[Observation.value[x]](StructureDefinition-hiv-b-de225.html)|
|HIV.B.DE226|Syndrome/STI diagnosed|Syndrome or STI for which client is diagnosed|string|[Observation.value[x]](StructureDefinition-hiv-b-de226.html)|
|HIV.B.DE235|Any STI syndrome diagnosed|Was the client diagnosed with any of the five STI syndromes during this visit?|string|[Observation.value[x]](StructureDefinition-hiv-b-de235.html)|
|HIV.B.DE236|Date of STI test|Date on which the STI test was conducted|string|[Observation.value[x]](StructureDefinition-hiv-b-de236.html)|
|HIV.B.DE237|STI tested for|STI for which the client was tested|string|[Observation.value[x]](StructureDefinition-hiv-b-de237.html)|
|HIV.B.DE249|Syphilis test date|Date of syphilis test|string|[Observation.value[x]](StructureDefinition-hiv-b-de249.html)|
|HIV.B.DE250|Syphilis test result|Result from syphilis test|string|[Observation.value[x]](StructureDefinition-hiv-b-de250.html)|
|HIV.B.DE254|Syphilis treatment start date|Date of initiation of syphilis treatment|string|[Observation.value[x]](StructureDefinition-hiv-b-de254.html)|
|HIV.B.DE255|Gonorrhoea test date|Date of Gonorrhoea test|string|[Observation.value[x]](StructureDefinition-hiv-b-de255.html)|
|HIV.B.DE256|Gonorrhoea test result|Result from Gonorrhoea test|string|[Observation.value[x]](StructureDefinition-hiv-b-de256.html)|
|HIV.B.DE260|Gonorrhoea treatment start date|Date of initiation of Gonorrhoea treatment|string|[Observation.value[x]](StructureDefinition-hiv-b-de260.html)|
|HIV.B.DE261|Type of specimen|Type of specimen to be collected|string|[Observation.value[x]](StructureDefinition-hiv-b-de261.html)|
|HIV.B.DE268|Other type of specimen (specify)|Other specimen type to be collected (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de268.html)|
|HIV.B.DE269|Syphilis test type|Type of diagnostic test used for syphilis (treponema pallidum)|string|[Observation.value[x]](StructureDefinition-hiv-b-de269.html)|
|HIV.B.DE275|Other syphilis test type (specify)|Other test used (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de275.html)|
|HIV.B.DE276|Neisseria gonorrhoeae test type|Type of diagnostic test used for Neisseria gonorrhoeae|string|[Observation.value[x]](StructureDefinition-hiv-b-de276.html)|
|HIV.B.DE283|POC Test for Neisseria gonorrhoeae (specify)|Point-of-care (POC) test used for Neisseria gonorrhoeae (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de283.html)|
|HIV.B.DE284|Chlamydia trachomatis test type|Type of diagnostic test used for Chlamydia trachomatis|string|[Observation.value[x]](StructureDefinition-hiv-b-de284.html)|
|HIV.B.DE29|Currently pregnant|Client is currently pregnant|string|[Observation.value[x]](StructureDefinition-hiv-b-de29.html)|
|HIV.B.DE291|Other test for Chlamydia (specify)|Other type of test used for Chlaymdia (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de291.html)|
|HIV.B.DE292|POC Test type for Chlamydia test (specify)|Point-of-care (POC) test used for Chlamydia (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de292.html)|
|HIV.B.DE293|Trichomonas vaginalis test type|Type of diagnostic test used for Trichomonas vaginalis|string|[Observation.value[x]](StructureDefinition-hiv-b-de293.html)|
|HIV.B.DE30|Gestational age|Gestational age in weeks and/or days depending on the source of gestational age|string|[Observation.value[x]](StructureDefinition-hiv-b-de30.html)|
|HIV.B.DE300|POC Test type for Trichomonas vaginalis test (specify)|Point-of-care (POC) test used (specify)|string|[Observation.value[x]](StructureDefinition-hiv-b-de300.html)|
|HIV.B.DE301|Herpes simplex virus (HSV) test type|Type of diagnostic test used for herpes simplex virus (HSV)|string|[Observation.value[x]](StructureDefinition-hiv-b-de301.html)|
|HIV.B.DE306|Mycoplasma genitalium test type|Type of diagnostic test used for Mycoplasma genitalium|string|[Observation.value[x]](StructureDefinition-hiv-b-de306.html)|
|HIV.B.DE31|Expected date of delivery (EDD)|Expected date of delivery based on gestational age|string|[Observation.value[x]](StructureDefinition-hiv-b-de31.html)|
|HIV.B.DE311|Test type for other STI tested for (specify)|Test type used for the other specified STI|string|[Observation.value[x]](StructureDefinition-hiv-b-de311.html)|
|HIV.B.DE312|STI test result|Result from STI test|string|[Observation.value[x]](StructureDefinition-hiv-b-de312.html)|
|HIV.B.DE316|Date of STI confirmatory test|Date of STI confirmatory test|string|[Observation.value[x]](StructureDefinition-hiv-b-de316.html)|
|HIV.B.DE317|Confirmatory syphilis test type|Type of test ued for confirmatory syphilis test|string|[Observation.value[x]](StructureDefinition-hiv-b-de317.html)|
|HIV.B.DE32|Breastfeeding|Infant is being breastfed by mother|string|[Observation.value[x]](StructureDefinition-hiv-b-de32.html)|
|HIV.B.DE324|Confirmatory test type for other STI (specify)|Confirmatory test type for other STI|string|[Observation.value[x]](StructureDefinition-hiv-b-de324.html)|
|HIV.B.DE325|Confirmatory STI test result|Result from confirmatory STI test|string|[Observation.value[x]](StructureDefinition-hiv-b-de325.html)|
|HIV.B.DE329|Date STI treatment prescribed|Date STI treatment was prescribed to the client|string|[Observation.value[x]](StructureDefinition-hiv-b-de329.html)|
|HIV.B.DE33|Partner HIV status (reported)|The HIV status of the client's partner.|string|[Observation.value[x]](StructureDefinition-hiv-b-de33.html)|
|HIV.B.DE330|Date STI treatment dispensed|Date STI treatment dispensed to the client|string|[Observation.value[x]](StructureDefinition-hiv-b-de330.html)|
|HIV.B.DE331|STI treatment dispensed (specify)|STI treatment dispensed to the client|string|[Observation.value[x]](StructureDefinition-hiv-b-de331.html)|
|HIV.B.DE37|Partner is from a key population*|Client's partner is a member of a key population, that has an increased risk of HIV|string|[Observation.value[x]](StructureDefinition-hiv-b-de37.html)|
|HIV.B.DE43|Has used an HIV self-test before (reported)|The client reported having used an HIV self-test before|string|[Observation.value[x]](StructureDefinition-hiv-b-de43.html)|
|HIV.B.DE44|HIV self-test result|Results from the reported HIV self-test|string|[Observation.value[x]](StructureDefinition-hiv-b-de44.html)|
|HIV.B.DE45|Reactive|The HIV self-test was reactive|string|[Observation.value[x]](StructureDefinition-hiv-b-de45.html)|
|HIV.B.DE46|Non-reactive|The HIV self-test was non-reactive|string|[Observation.value[x]](StructureDefinition-hiv-b-de46.html)|
|HIV.B.DE47|Invalid|The HIV self-test was invalid|string|[Observation.value[x]](StructureDefinition-hiv-b-de47.html)|
|HIV.B.DE48|Date of HIV self-test|Date when the HIV self-test was conducted|string|[Observation.value[x]](StructureDefinition-hiv-b-de48.html)|
|HIV.B.DE49|Key population member*|Client is a member of a key population that has an increased risk of HIV|string|[Observation.value[x]](StructureDefinition-hiv-b-de49.html)|
|HIV.B.DE5|Referred through partner services|Client reported coming to the facility after receiving a provider-assisted referral or patient referral from a contact or partner|string|[Observation.value[x]](StructureDefinition-hiv-b-de5.html)|
|HIV.B.DE50|Key population member type*|The type of key population that the client is included in|string|[Observation.value[x]](StructureDefinition-hiv-b-de50.html)|
|HIV.B.DE56|Adolescent girl|Calculated field based on age and gender, if client is 10 years or older and under 20 years old|string|[Observation.value[x]](StructureDefinition-hiv-b-de56.html)|
|HIV.B.DE57|Young woman|Calculated field based on age and gender, if client is 20 years or older and under 25 years old|string|[Observation.value[x]](StructureDefinition-hiv-b-de57.html)|
|HIV.B.DE58|Orphan or vulnerable child|Client considered an orphan or vulnerable child|string|[Observation.value[x]](StructureDefinition-hiv-b-de58.html)|
|HIV.B.DE59|Informed of HIV test result|Client has been informed of their HIV test result|string|[Observation.value[x]](StructureDefinition-hiv-b-de59.html)|
|HIV.B.DE60|Date HIV test results returned|Date HIV test result returned to client|string|[Observation.value[x]](StructureDefinition-hiv-b-de60.html)|
|HIV.B.DE61|HIV exposure type*|Ways in which the client was exposed to HIV|string|[Observation.value[x]](StructureDefinition-hiv-b-de61.html)|
|HIV.B.DE65|Date informed of HIV-positive diagnosis|The date on which the client was diagnosed with HIV|string|[Observation.value[x]](StructureDefinition-hiv-b-de65.html)|
|HIV.B.DE66|HIV diagnosing facility|The facility where the client received an HIV-positive diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-b-de66.html)|
|HIV.B.DE67|Date of first positive test indicative of HIV diagnosis|Earliest date of HIV diagnosis determined according to the national HIV testing algorithm|string|[Observation.value[x]](StructureDefinition-hiv-b-de67.html)|
|HIV.B.DE68|HIV serotype|The client's HIV serotype|string|[Observation.value[x]](StructureDefinition-hiv-b-de68.html)|
|HIV.B.DE71|HIV diagnosis date|Date diagnosis was returned to client|string|[Observation.value[x]](StructureDefinition-hiv-b-de71.html)|
|HIV.B.DE72|ART start date|The date on which the client started or restarted antiretroviral therapy (ART)|string|[Observation.value[x]](StructureDefinition-hiv-b-de72.html)|
|HIV.B.DE73|Age at diagnosis|The client's age (in years) when given an HIV diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-b-de73.html)|
|HIV.B.DE74|Type of contact elicited|Client's relationship to the contact identified for voluntary partner services or family services|string|[Observation.value[x]](StructureDefinition-hiv-b-de74.html)|
|HIV.B.DE79|HIV test ordered|An HIV test of the client was ordered by the provider|string|[Observation.value[x]](StructureDefinition-hiv-b-de79.html)|
|HIV.B.DE8|Type of contact or partner for partner services|Client's relationship to the person that referred the client for partner services or family services|string|[Observation.value[x]](StructureDefinition-hiv-b-de8.html)|
|HIV.B.DE80|HIV test conducted|An HIV test was performed on the client during the visit|string|[Observation.value[x]](StructureDefinition-hiv-b-de80.html)|
|HIV.B.DE81|HIV test type|Type of HIV test|string|[Observation.value[x]](StructureDefinition-hiv-b-de81.html)|
|HIV.B.DE87|Date HIV test sent|Date HIV specimen was sent to lab|string|[Observation.value[x]](StructureDefinition-hiv-b-de87.html)|
|HIV.B.DE88|Assay number in testing strategy|The number of the assay (test kit) in the HIV testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de88.html)|
|HIV.B.DE89|Assay 0|A community outreach test-for-triage or self-test which is not included in the HIV testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de89.html)|
|HIV.B.DE90|Assay 1|The first test in the HIV testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de90.html)|
|HIV.B.DE91|Assay 2|The second test in the HIV testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de91.html)|
|HIV.B.DE92|Assay 3|The third test in the HIV testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de92.html)|
|HIV.B.DE93|Assay 1 repeated|The first test in the HIV testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de93.html)|
|HIV.B.DE94|Test result of HIV assay 1|The result of the first HIV assay in the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de94.html)|
|HIV.B.DE98|Test result of HIV assay 2|The result of the second HIV assay in the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-b-de98.html)|
|HIV.C.DE1|Reason for PrEP visit|Client's reason for the prevention visit|string|[Observation.value[x]](StructureDefinition-hiv-c-de1.html)|
|HIV.C.DE10|Currently on PrEP|The client is currently taking PrEP. Oral pre-exposure prophylaxis (PrEP) of HIV is the use of ARV drugs by people who are not infected with HIV to block the acquisition of HIV.|string|[Observation.value[x]](StructureDefinition-hiv-c-de10.html)|
|HIV.C.DE101|Alternative third PEP drug|Alternative third drug for PEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de101.html)|
|HIV.C.DE106|Estimated creatinine clearance|Estimated creatinine clearance of the client returned from lab in mL/min|string|[Observation.value[x]](StructureDefinition-hiv-c-de106.html)|
|HIV.C.DE107|Sex factor for estimating creatinine clearance|Value used for gender for calculating creatinine clearance if required. For transgender populations, the sex at birth is used in the Cockcroft-Gault equation if the person is not using hormone therapy; among transgender populations using hormone therapy for more than three months, the current gender can be used.|string|[Observation.value[x]](StructureDefinition-hiv-c-de107.html)|
|HIV.C.DE11|PrEP dosing type|Way in which pre-exposure prophylaxis (PrEP) is taken (daily or event-driven)|string|[Observation.value[x]](StructureDefinition-hiv-c-de11.html)|
|HIV.C.DE110|Estimated creatinine clearance (Cockcroft-Gault equation)|If the laboratory does not have the capacity to estimate creatinine clearance, the provider can use the Cockcroft–Gault equation to calculate estimated creatinine clearance based on measured serum creatinine, the client’s sex at birth, age and estimated lean body weight.|string|[Observation.value[x]](StructureDefinition-hiv-c-de110.html)|
|HIV.C.DE111|Date of sample collection|Date when the specimen was collected|string|[Observation.value[x]](StructureDefinition-hiv-c-de111.html)|
|HIV.C.DE112|Contraindications to PrEP usage|Listing of contraindications to pre-exposure prophylaxis (PrEP)|string|[Observation.value[x]](StructureDefinition-hiv-c-de112.html)|
|HIV.C.DE119|Other allergy or contraindication to a medicine in the PrEP regimen (specify)|Client has another allergy or contraindication to a medicine in the pre-exposure prophylaxis (PrEP) regimen (specify)|string|[Observation.value[x]](StructureDefinition-hiv-c-de119.html)|
|HIV.C.DE120|Prescribed PrEP at initial visit|Client was prescribed pre-exposure prophylaxis (PrEP) on a first visit|string|[Observation.value[x]](StructureDefinition-hiv-c-de120.html)|
|HIV.C.DE121|Number of days prescribed|Days of medication client has been prescribed|string|[Observation.value[x]](StructureDefinition-hiv-c-de121.html)|
|HIV.C.DE122|PrEP regimen prescribed|HIV pre-exposure prophylaxis (PrEP) regimen prescribed|string|[Observation.value[x]](StructureDefinition-hiv-c-de122.html)|
|HIV.C.DE123|Adherence counselling provided|Whether adherence counselling was provided|string|[Observation.value[x]](StructureDefinition-hiv-c-de123.html)|
|HIV.C.DE130|Linked to enrolment in care and ART initiation|Linkage made from HIV testing to enrolment in care following an HIV diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-c-de130.html)|
|HIV.C.DE136|Date provided condoms|Date client was provided with condoms|string|[Observation.value[x]](StructureDefinition-hiv-c-de136.html)|
|HIV.C.DE137|Condoms distributed|Number of condoms given to the client, if any were distributed|string|[Observation.value[x]](StructureDefinition-hiv-c-de137.html)|
|HIV.C.DE138|Condom type|Type of condom provided to client|string|[Observation.value[x]](StructureDefinition-hiv-c-de138.html)|
|HIV.C.DE141|HIV self-test kits accepted|Whether any HIV self-test kits were given to the client|string|[Observation.value[x]](StructureDefinition-hiv-c-de141.html)|
|HIV.C.DE142|Number of HIV self-test kits distributed|Number of HIV self-test kits distributed to the client|string|[Observation.value[x]](StructureDefinition-hiv-c-de142.html)|
|HIV.C.DE143|HIV self-test distributed for use by|Whom the client plans to give the HIV self-test kit (self, sexual partner, social contact, etc.)|string|[Observation.value[x]](StructureDefinition-hiv-c-de143.html)|
|HIV.C.DE15|Other PrEP dosing type (specify)|Other PrEP dosing type (specify)|string|[Observation.value[x]](StructureDefinition-hiv-c-de15.html)|
|HIV.C.DE156|HIV testing for partners and biological children|Offer testing for all partners and biological children of positive cases (includes partner services and index case testing), as well as partners and social contacts of people from key populations, where appropriate|string|[Observation.value[x]](StructureDefinition-hiv-c-de156.html)|
|HIV.C.DE16|Used event-driven PrEP for at risk exposures over the past 3 months|Client reports taking ED-PrEP for at risk exposures over a 3-month period|string|[Observation.value[x]](StructureDefinition-hiv-c-de16.html)|
|HIV.C.DE17|Current PrEP regimen|HIV pre-exposure prophylaxis (PrEP) regimen|string|[Observation.value[x]](StructureDefinition-hiv-c-de17.html)|
|HIV.C.DE24|Experience with PrEP|The client's experience in taking PrEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de24.html)|
|HIV.C.DE28|PrEP start date|The date on which the client started or restarted pre-exposure prophylaxis (PrEP)|string|[Observation.value[x]](StructureDefinition-hiv-c-de28.html)|
|HIV.C.DE29|Stopped PrEP|Client stopped taking pre-exposure prophylaxis (PrEP)|string|[Observation.value[x]](StructureDefinition-hiv-c-de29.html)|
|HIV.C.DE30|Date PrEP stopped|Date client stopped taking pre-exposure prophylaxis (PrEP)|string|[Observation.value[x]](StructureDefinition-hiv-c-de30.html)|
|HIV.C.DE31|PEP history|The client's history in taking post-exposure prophylaxis (PEP) for HIV prevention|string|[Observation.value[x]](StructureDefinition-hiv-c-de31.html)|
|HIV.C.DE34|Date(s) of past PEP use|Dates when the client previously used post-exposure prophylaxis (PEP)|string|[Observation.value[x]](StructureDefinition-hiv-c-de34.html)|
|HIV.C.DE35|Date client completes PEP course|Date client completes PEP course|string|[Observation.value[x]](StructureDefinition-hiv-c-de35.html)|
|HIV.C.DE36|Signs of substantial risk of HIV infection|Signs the client is at a substantial risk of HIV infection|string|[Observation.value[x]](StructureDefinition-hiv-c-de36.html)|
|HIV.C.DE41|Pregnancy intention in serodiscordant partnerships|Client's intention or desire in the next year to either become pregnant or prevent a future pregnancy (in serodiscordant partnerships)|string|[Observation.value[x]](StructureDefinition-hiv-c-de41.html)|
|HIV.C.DE46|Acute HIV infection symptoms|Symptoms that could suggest an acute HIV infection|string|[Observation.value[x]](StructureDefinition-hiv-c-de46.html)|
|HIV.C.DE55|Sex partner's HIV treatment status|Treatment adherence of client's sex partner for partners that are HIV-positive|string|[Observation.value[x]](StructureDefinition-hiv-c-de55.html)|
|HIV.C.DE61|Suitable for PrEP|The client is suitable for PrEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de61.html)|
|HIV.C.DE62|Offered PrEP|After being evaluated as suitable for PrEP, the client was offered PrEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de62.html)|
|HIV.C.DE63|Screenings and diagnostics for PrEP users|Listing of tests for clients on or starting pre-exposure prophylaxis (PrEP) that may be recommended or should be considered|string|[Observation.value[x]](StructureDefinition-hiv-c-de63.html)|
|HIV.C.DE7|3-month PrEP visit|Client is visiting for the recommended 3-month pre-exposure prophylaxis (PrEP) visit|string|[Observation.value[x]](StructureDefinition-hiv-c-de7.html)|
|HIV.C.DE71|Serum creatinine test date|Test serum creatinine to identify pre-existing renal disease (estimated creatinine clearance less than 60 ml/min)|string|[Observation.value[x]](StructureDefinition-hiv-c-de71.html)|
|HIV.C.DE72|Serum creatinine test result|Test serum creatinine to identify pre-existing renal disease (estimated creatinine clearance less than 60 ml/min).|string|[Observation.value[x]](StructureDefinition-hiv-c-de72.html)|
|HIV.C.DE73|Date medications dispensed|Date the client was dispensed medications|string|[Observation.value[x]](StructureDefinition-hiv-c-de73.html)|
|HIV.C.DE74|Date medications prescribed|Date the client was prescribed medications|string|[Observation.value[x]](StructureDefinition-hiv-c-de74.html)|
|HIV.C.DE75|Medications prescribed|Medications the client was prescribed|string|[Observation.value[x]](StructureDefinition-hiv-c-de75.html)|
|HIV.C.DE80|PrEP product prescribed|PrEP product that the client was prescribed|string|[Observation.value[x]](StructureDefinition-hiv-c-de80.html)|
|HIV.C.DE86|Date PrEP prescribed|Date client was prescribed PrEP, including initial prescription and repeats|string|[Observation.value[x]](StructureDefinition-hiv-c-de86.html)|
|HIV.C.DE87|Date PrEP dispensed|Date client was dispensed PrEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de87.html)|
|HIV.C.DE88|Volume of PrEP product prescribed/dispensed|Volume of PrEP product the client was prescribed or dispensed (for example, number of pills, number of devices)|string|[Observation.value[x]](StructureDefinition-hiv-c-de88.html)|
|HIV.C.DE89|Date PEP prescribed|Date the client was prescribed PEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de89.html)|
|HIV.C.DE90|Date PEP course completion|Date client completes PEP course|string|[Observation.value[x]](StructureDefinition-hiv-c-de90.html)|
|HIV.C.DE91|Preferred PEP backbone regimen|Preferred backbone regimen for PEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de91.html)|
|HIV.C.DE95|Alternative PEP backbone regimen|Alternative backbone regimen for PEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de95.html)|
|HIV.C.DE99|Preferred third PEP drug|Preferred third drug for PEP|string|[Observation.value[x]](StructureDefinition-hiv-c-de99.html)|
|HIV.Config.DE1|Population prevalence of TB|The tuberculosis prevalence in the general population in number of cases per 100 000 persons or greater.|string|[Observation.value[x]](StructureDefinition-hiv-config-de1.html)|
|HIV.Config.DE10|Prevalence of HIV in the catchment area|The proportion of the population from the health facility's catchment area that are HIV-positive (estimated)|string|[Observation.value[x]](StructureDefinition-hiv-config-de10.html)|
|HIV.Config.DE11|Ultrasound available at the health facility|Whether an ultrasound machine is available and functional in the facility and a trained health worker is available to use it|string|[Observation.value[x]](StructureDefinition-hiv-config-de11.html)|
|HIV.Config.DE12|HIV burden of the setting|HIV burden of the setting (high or low) based on the national HIV prevalence or where the HIV prevalence and/or incidence in a geographical setting is higher than national prevalence and, therefore, needs priority in the HIV response|string|[Observation.value[x]](StructureDefinition-hiv-config-de12.html)|
|HIV.Config.DE15|HPV DNA testing operational at the health facility|Is HPV DNA testing operational at the health facility for cervical cancer screening?|string|[Observation.value[x]](StructureDefinition-hiv-config-de15.html)|
|HIV.Config.DE16|Routine viral load testing is available|Routine viral load testing is available in the facility|string|[Observation.value[x]](StructureDefinition-hiv-config-de16.html)|
|HIV.Config.DE17|Health facility ID|Unique ID of the health facility that recorded the client. This ID could represent a universal health facility ID, if used in the country. Alternatively this ID can also be generated by the national surveillance system and assigned to reporting facility.|string|[Observation.value[x]](StructureDefinition-hiv-config-de17.html)|
|HIV.Config.DE18|TB treating facility ID|The facility where the client is receiving tuberculosis (TB) treatment|string|[Observation.value[x]](StructureDefinition-hiv-config-de18.html)|
|HIV.Config.DE19|Other priority populations|Other populations of priority of HIV prevention and care in local context (provided during adaptation)|string|[Observation.value[x]](StructureDefinition-hiv-config-de19.html)|
|HIV.Config.DE2|Population prevalence of soil-transmitted helminth infection|The percentage of individuals in the general population infected with at least one species of soil-transmitted helminths|string|[Observation.value[x]](StructureDefinition-hiv-config-de2.html)|
|HIV.Config.DE20|Reporting period end date|End date of the reporting period|string|[Observation.value[x]](StructureDefinition-hiv-config-de20.html)|
|HIV.Config.DE21|Reporting period start date|Start date of the reporting period|string|[Observation.value[x]](StructureDefinition-hiv-config-de21.html)|
|HIV.Config.DE22|Reporting date|Reporting date, for surveys performed on a specific date|string|[Observation.value[x]](StructureDefinition-hiv-config-de22.html)|
|HIV.Config.DE3|Population incidence of HIV in the absence of PrEP|HIV incidence number of cases per 100 person–years in the absence of PrEP|string|[Observation.value[x]](StructureDefinition-hiv-config-de3.html)|
|HIV.Config.DE4|Population prevalence of HIV|The proportion of the population that are HIV-positive|string|[Observation.value[x]](StructureDefinition-hiv-config-de4.html)|
|HIV.Config.DE5|Prevalence of pretreatment NNRTI drug resistance|Prevalence of pretreatment HIV drug resistance to NNRTIs among people initiating first-line ART|string|[Observation.value[x]](StructureDefinition-hiv-config-de5.html)|
|HIV.Config.DE6|Malaria-endemic setting|Whether the setting is a malaria-endemic setting|string|[Observation.value[x]](StructureDefinition-hiv-config-de6.html)|
|HIV.Config.DE7|Population prevalence of syphilis|The proportion of the population with syphilis|string|[Observation.value[x]](StructureDefinition-hiv-config-de7.html)|
|HIV.Config.DE8|Population prevalence of hepatitis B|The proportion of hepatitis B surface antigen (HBsAg) seroprevalence in the general population|string|[Observation.value[x]](StructureDefinition-hiv-config-de8.html)|
|HIV.Config.DE9|Population prevalence of hepatitis C|The proportion of hepatitis C virus (HCV) antibody seroprevalence in the general population|string|[Observation.value[x]](StructureDefinition-hiv-config-de9.html)|
|HIV.D.DE10|Respiratory rate|The number of breaths per minute|string|[Observation.value[x]](StructureDefinition-hiv-d-de10.html)|
|HIV.D.DE1000|TB treatment started|Indicates if TB treatment was started|string|[Observation.value[x]](StructureDefinition-hiv-d-de1000.html)|
|HIV.D.DE1001|TB treatment start date|The date on which the client start or restarted tuberculosis (TB) treatment|string|[Observation.value[x]](StructureDefinition-hiv-d-de1001.html)|
|HIV.D.DE1002|TB treatment outcome|Indicates patient's TB treatment outcome|string|[Observation.value[x]](StructureDefinition-hiv-d-de1002.html)|
|HIV.D.DE1009|TB treatment completion date|Date client completes TB treatment|string|[Observation.value[x]](StructureDefinition-hiv-d-de1009.html)|
|HIV.D.DE1010|TB treatment regimen composition|TB drugs currently being taken by the client|string|[Observation.value[x]](StructureDefinition-hiv-d-de1010.html)|
|HIV.D.DE1017|Eligible for TB preventive treatment|Client is eligible for tuberculosis preventive treatment (TPT)|string|[Observation.value[x]](StructureDefinition-hiv-d-de1017.html)|
|HIV.D.DE1018|Date when eligibility for TB preventive treatment (TPT) was determined|Date when a determination of the client's eligibility for TPT was made|string|[Observation.value[x]](StructureDefinition-hiv-d-de1018.html)|
|HIV.D.DE1019|TB status at ART start|Client's tuberculosis (TB) status when antiretroviral therapy (ART) is started|string|[Observation.value[x]](StructureDefinition-hiv-d-de1019.html)|
|HIV.D.DE1023|TB prevention services accepted|Indicates if the client accepts to be evaluated for TB infection and to take the treatment in case he/she is eligible|string|[Observation.value[x]](StructureDefinition-hiv-d-de1023.html)|
|HIV.D.DE1024|TB meningitis|Type of extrapulmonary TB identified for the client is TB meningitis|string|[Observation.value[x]](StructureDefinition-hiv-d-de1024.html)|
|HIV.D.DE1025|C reactive protein test date|The date on which the client has a test for C reactive protein|string|[Observation.value[x]](StructureDefinition-hiv-d-de1025.html)|
|HIV.D.DE1026|C reactive protein test result|Test result of the client's C reactive protein test result in mg/L|string|[Observation.value[x]](StructureDefinition-hiv-d-de1026.html)|
|HIV.D.DE1027|C reactive protein test result date|The date when the client's test result for C reactive protein is available|string|[Observation.value[x]](StructureDefinition-hiv-d-de1027.html)|
|HIV.D.DE1028|TPT regimen type|Type of TPT regimen the client is currently on|string|[Observation.value[x]](StructureDefinition-hiv-d-de1028.html)|
|HIV.D.DE1034|TB preventive treatment (TPT) status|Indicates the current status of TB preventive treatment (TPT)|string|[Observation.value[x]](StructureDefinition-hiv-d-de1034.html)|
|HIV.D.DE11|Heart rate|The number of heartbeats per minute|string|[Observation.value[x]](StructureDefinition-hiv-d-de11.html)|
|HIV.D.DE12|Body height|The client's height in centimetres|string|[Observation.value[x]](StructureDefinition-hiv-d-de12.html)|
|HIV.D.DE128|ART regimen composition|Drug composition of client's current ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de128.html)|
|HIV.D.DE13|Body weight|The client's current weight in kilograms|string|[Observation.value[x]](StructureDefinition-hiv-d-de13.html)|
|HIV.D.DE14|Systolic blood pressure|Systolic blood pressure (SBP) in mmHg|string|[Observation.value[x]](StructureDefinition-hiv-d-de14.html)|
|HIV.D.DE146|ART regimen drug class|Drug class of current ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de146.html)|
|HIV.D.DE15|Diastolic blood pressure|Diastolic blood pressure (DBP) in mmHg|string|[Observation.value[x]](StructureDefinition-hiv-d-de15.html)|
|HIV.D.DE16|Blood pressure cannot be taken|If the client's blood pressure cannot be taken, this should be indicated here. Otherwise, blood pressure should be measured.|string|[Observation.value[x]](StructureDefinition-hiv-d-de16.html)|
|HIV.D.DE161|HBsAg test date|Date client was tested for hepatitis B virus (HBV)|string|[Observation.value[x]](StructureDefinition-hiv-d-de161.html)|
|HIV.D.DE162|HBsAg test result|Hepatitis B virus test result (HBsAg)|string|[Observation.value[x]](StructureDefinition-hiv-d-de162.html)|
|HIV.D.DE166|Date HBV test result returned to client|Date HBV test result (HBsAG) was returned to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de166.html)|
|HIV.D.DE167|HBV treatment (TDF) start date|Date when client started treatment (TDF) for hepatitis B virus (HBV)|string|[Observation.value[x]](StructureDefinition-hiv-d-de167.html)|
|HIV.D.DE168|HBV treatment regimen prescribed|Hepatitis B virus treatment regimen prescribed|string|[Observation.value[x]](StructureDefinition-hiv-d-de168.html)|
|HIV.D.DE169|HCV test date|Date client was tested for hepatitis C virus (HCV antibody, HCV RNA or HCV core antigen)|string|[Observation.value[x]](StructureDefinition-hiv-d-de169.html)|
|HIV.D.DE17|Signs of serious illness|Signs that may indicate the client has a serious illness and needs triage or an emergency referral|string|[Observation.value[x]](StructureDefinition-hiv-d-de17.html)|
|HIV.D.DE170|HCV test result|Hepatitis C virus test result (HCV antibody, HCV RNA or HCV core antigen)|string|[Observation.value[x]](StructureDefinition-hiv-d-de170.html)|
|HIV.D.DE174|Date HCV test result returned to client|Date HCV test result was returned to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de174.html)|
|HIV.D.DE175|HCV treatment start date|Date when client started treatment for hepatitis C virus (HCV)|string|[Observation.value[x]](StructureDefinition-hiv-d-de175.html)|
|HIV.D.DE176|HCV treatment completion date|Date when client completed treatment for hepatitis C virus (HCV)|string|[Observation.value[x]](StructureDefinition-hiv-d-de176.html)|
|HIV.D.DE177|HCV treatment regimen prescribed|Hepatitis C virus treatment regimen prescribed|string|[Observation.value[x]](StructureDefinition-hiv-d-de177.html)|
|HIV.D.DE178|HCV viral load test date|Hepatitis C viral load test date|string|[Observation.value[x]](StructureDefinition-hiv-d-de178.html)|
|HIV.D.DE179|HCV viral load test result|Hepatitis C viral load test result (qualitative)|string|[Observation.value[x]](StructureDefinition-hiv-d-de179.html)|
|HIV.D.DE182|HCV medicine type|Type of medicine client is prescribed|string|[Observation.value[x]](StructureDefinition-hiv-d-de182.html)|
|HIV.D.DE185|Currently on TDF-based ART|Client is currently on TDF-based ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de185.html)|
|HIV.D.DE186|HIV clinical stage|WHO clinical stage of client based on signs and symptoms. WHO clinical staging is a way to categorize HIV disease severity based on new or recurrent clinical events. There are 4 WHO clinical stages that range from mild symptoms (WHO clinical stage 1) to severe symptoms (WHO clinical stage 4).|string|[Observation.value[x]](StructureDefinition-hiv-d-de186.html)|
|HIV.D.DE191|Number of missed doses|Number of doses of antiretroviral therapy (ART) the client missed since the last visit, used for monitoring adherence|string|[Observation.value[x]](StructureDefinition-hiv-d-de191.html)|
|HIV.D.DE192|Received viral load test result|Client received results from viral load test|string|[Observation.value[x]](StructureDefinition-hiv-d-de192.html)|
|HIV.D.DE193|Date viral load test results received by client|The date on which the client received results from viral load test|string|[Observation.value[x]](StructureDefinition-hiv-d-de193.html)|
|HIV.D.DE194|Date of viral load sample collection|Date and time when the sample was collected to test the client's HIV viral load|string|[Observation.value[x]](StructureDefinition-hiv-d-de194.html)|
|HIV.D.DE195|Date of scheduled review of viral load test results|Expected date when client's viral load test results will be returned and reviewed|string|[Observation.value[x]](StructureDefinition-hiv-d-de195.html)|
|HIV.D.DE196|Date of ART interruption|Date of client's ART interruption (ART stop or missed drug pick-up)|string|[Observation.value[x]](StructureDefinition-hiv-d-de196.html)|
|HIV.D.DE197|Reason(s) for adherence problem|Reason why client was not adherent|string|[Observation.value[x]](StructureDefinition-hiv-d-de197.html)|
|HIV.D.DE216|Other reason for nonadherence (specify)|Client reported not being adherent because of other reason for nonadherence (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de216.html)|
|HIV.D.DE217|Reason ART stopped|Reason client intentionally stopped ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de217.html)|
|HIV.D.DE224|Other reason for stopping ART (specify)|Client stopped ART because of other reason (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de224.html)|
|HIV.D.DE225|Treatment failure|ART treatment failure|string|[Observation.value[x]](StructureDefinition-hiv-d-de225.html)|
|HIV.D.DE229|General care activities recommended|General care activities to be performed during the care visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de229.html)|
|HIV.D.DE247|Preventing and treating coinfections|Coinfection prevention and treatment activities performed during the care visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de247.html)|
|HIV.D.DE259|Risk factors, comorbidities and coinfections signs and symptoms|Signs and symptoms of opportunistic infections or other comorbidities experienced by client|string|[Observation.value[x]](StructureDefinition-hiv-d-de259.html)|
|HIV.D.DE289|WHO HIV clinical stage condition or symptom|New or recurrent clinical events used to categorize HIV disease severity based at baseline and follow up|string|[Observation.value[x]](StructureDefinition-hiv-d-de289.html)|
|HIV.D.DE30|Other sign of serious illness (specify)|Client is exhibiting another sign of a serious illness (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de30.html)|
|HIV.D.DE33|Number of pregnancies (gravida)|Total number of times the woman has been pregnant (gravida)|string|[Observation.value[x]](StructureDefinition-hiv-d-de33.html)|
|HIV.D.DE34|Number of miscarriages and/or abortions|Total number of pregnancies lost/ended due to miscarriages and/or abortions before 22 weeks/5 months|string|[Observation.value[x]](StructureDefinition-hiv-d-de34.html)|
|HIV.D.DE35|Number of live births|Total number of live births after 22 weeks|string|[Observation.value[x]](StructureDefinition-hiv-d-de35.html)|
|HIV.D.DE358|Clinical stage at start of ART|WHO clinical stage of client based on signs and symptoms at start of ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de358.html)|
|HIV.D.DE36|Parity|Calculated parity is the total number of live and stillbirths|string|[Observation.value[x]](StructureDefinition-hiv-d-de36.html)|
|HIV.D.DE363|Date of clinical status change|Date on which the client's WHO HIV clinical stage changed, including the date when the client's stage is first determined|string|[Observation.value[x]](StructureDefinition-hiv-d-de363.html)|
|HIV.D.DE364|CD4 count|CD4 cell count in cells/mm^3|string|[Observation.value[x]](StructureDefinition-hiv-d-de364.html)|
|HIV.D.DE365|CD4 cell percentage|CD4 cell percentage|string|[Observation.value[x]](StructureDefinition-hiv-d-de365.html)|
|HIV.D.DE366|Date of CD4 count test|Date and time when CD4 count test was conducted|string|[Observation.value[x]](StructureDefinition-hiv-d-de366.html)|
|HIV.D.DE367|Baseline CD4 count|CD4 count performed at HIV diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-d-de367.html)|
|HIV.D.DE368|Date of baseline CD4 count test|Date and time when baseline CD4 count test was conducted|string|[Observation.value[x]](StructureDefinition-hiv-d-de368.html)|
|HIV.D.DE369|Late ART initiation|Client had late ART initiation. That is, the client's first CD4 count from baseline CD4 test performed (such as at HIV diagnosis) was a count of <200 cells/mm3|string|[Observation.value[x]](StructureDefinition-hiv-d-de369.html)|
|HIV.D.DE37|Serodiscordant partner|Client's HIV status is different from a current partner's HIV status|string|[Observation.value[x]](StructureDefinition-hiv-d-de37.html)|
|HIV.D.DE370|Reasons for delayed ART initiation|Reason why ART was not initiated at diagnosis or within 7 days of diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-d-de370.html)|
|HIV.D.DE38|On ART|Client is currently taking ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de38.html)|
|HIV.D.DE382|ART initiated within 7 days of diagnosis|Client initiated ART within 7 days of diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-d-de382.html)|
|HIV.D.DE383|Time to start ART|Time from HIV diagnosis to when client started ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de383.html)|
|HIV.D.DE387|Viral load test result|Result from the viral load test in number of copies/mL|string|[Observation.value[x]](StructureDefinition-hiv-d-de387.html)|
|HIV.D.DE388|Virally suppressed|The client is virally suppressed for HIV, based on the client's most recent viral load test result being less than 1000 copies/mL|string|[Observation.value[x]](StructureDefinition-hiv-d-de388.html)|
|HIV.D.DE389|Date viral load test results received|Date the viral load test result was received from the lab or completed in the facility|string|[Observation.value[x]](StructureDefinition-hiv-d-de389.html)|
|HIV.D.DE390|Viral load suppression date|Date on which the client tested as becoming virally suppressed, as indicated by a viral load test result under 1000 copies/mL|string|[Observation.value[x]](StructureDefinition-hiv-d-de390.html)|
|HIV.D.DE391|Reason for HIV viral load test|Whether the viral load is being tested for routine monitoring on a set schedule or for targeted monitoring for suspected treatment failure|string|[Observation.value[x]](StructureDefinition-hiv-d-de391.html)|
|HIV.D.DE396|Hepatitis B test required|Hepatitis B test is required|string|[Observation.value[x]](StructureDefinition-hiv-d-de396.html)|
|HIV.D.DE397|Hepatitis C test recommended|Hepatitis C test is recommended or should be considered|string|[Observation.value[x]](StructureDefinition-hiv-d-de397.html)|
|HIV.D.DE398|Syphilis test required|Syphilis test is required|string|[Observation.value[x]](StructureDefinition-hiv-d-de398.html)|
|HIV.D.DE399|Monitoring examinations|Name of examinations, test and results for any relevant investigations carried out for client|string|[Observation.value[x]](StructureDefinition-hiv-d-de399.html)|
|HIV.D.DE40|Stopped ART|Client stopped taking ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de40.html)|
|HIV.D.DE41|Date ART stopped|Date on which client stopped ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de41.html)|
|HIV.D.DE413|Date of scheduled monitoring examination|Date of scheduled monitoring examination|string|[Observation.value[x]](StructureDefinition-hiv-d-de413.html)|
|HIV.D.DE414|Hepatitis C test ordered|Hepatitis C test has been ordered|string|[Observation.value[x]](StructureDefinition-hiv-d-de414.html)|
|HIV.D.DE415|Syphilis test ordered|Syphilis test has been ordered|string|[Observation.value[x]](StructureDefinition-hiv-d-de415.html)|
|HIV.D.DE416|Received viral load test results|Client received results from viral load test|string|[Observation.value[x]](StructureDefinition-hiv-d-de416.html)|
|HIV.D.DE418|Reason for ARV drug regimen substitution|Reason why a substitution was made to the antiretroviral (ARV) drug regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de418.html)|
|HIV.D.DE42|Established on ART|Is the client successfully established on ART?|string|[Observation.value[x]](StructureDefinition-hiv-d-de42.html)|
|HIV.D.DE426|Other reason for regimen substitution (specify)|A substitution was made for another reason (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de426.html)|
|HIV.D.DE427|Switch to second-line ART regimen recommended|A switch to second-line ART regimen is recommended|string|[Observation.value[x]](StructureDefinition-hiv-d-de427.html)|
|HIV.D.DE428|Switch to third-line ART regimen recommended|A switch to third-line ART regimen is recommended|string|[Observation.value[x]](StructureDefinition-hiv-d-de428.html)|
|HIV.D.DE429|Regimen switch made|Provider has made a regimen switch|string|[Observation.value[x]](StructureDefinition-hiv-d-de429.html)|
|HIV.D.DE43|ART start type|Whether the client is ART naive or is restarting ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de43.html)|
|HIV.D.DE430|Reason for regimen switch|Reason why a switch to a second- or third-line regimen was made|string|[Observation.value[x]](StructureDefinition-hiv-d-de430.html)|
|HIV.D.DE436|Regimen substitution recommended|A drug substitution is recommended|string|[Observation.value[x]](StructureDefinition-hiv-d-de436.html)|
|HIV.D.DE437|Dose adjustment recommended|A dosage change is recommended|string|[Observation.value[x]](StructureDefinition-hiv-d-de437.html)|
|HIV.D.DE438|Regimen substitution made|Provider has made a regimen substitution|string|[Observation.value[x]](StructureDefinition-hiv-d-de438.html)|
|HIV.D.DE439|Co-trimoxazole prophylaxis start date|Date co-trimoxazole prophylaxis prescribed to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de439.html)|
|HIV.D.DE440|Co-trimoxazole prophylaxis completion date|Completion date of co-trimoxazole prophylaxis prescribed to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de440.html)|
|HIV.D.DE441|Co-trimoxazole prophylaxis dosage|Dose of co-trimoxazole prophylaxis prescribed to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de441.html)|
|HIV.D.DE442|Co-trimoxazole prophylaxis number of days prescribed|Number of days of co-trimoxazole prophylaxis prescribed to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de442.html)|
|HIV.D.DE443|Suspicion of treatment failure or interruption|Client has been on ART, but has stopped taking it or a treatment failure is suspected|string|[Observation.value[x]](StructureDefinition-hiv-d-de443.html)|
|HIV.D.DE444|ART regimen prescribed|INCLUDE VALUE SETS OF REGIMENS|string|[Observation.value[x]](StructureDefinition-hiv-d-de444.html)|
|HIV.D.DE445|Antiretroviral toxicity|Client is experiencing antiretroviral drug (ARV) toxicity|string|[Observation.value[x]](StructureDefinition-hiv-d-de445.html)|
|HIV.D.DE446|Coinfection status at ART start|Clients status of coinfections at the time when ART was initiated|string|[Observation.value[x]](StructureDefinition-hiv-d-de446.html)|
|HIV.D.DE449|Pregnant and breastfeeding status at ART start|ART status of women to prevent mother-to-child transmission|string|[Observation.value[x]](StructureDefinition-hiv-d-de449.html)|
|HIV.D.DE454|Delivery date of infant|Date of delivery/birth of infant if breastfeeding at ART start|string|[Observation.value[x]](StructureDefinition-hiv-d-de454.html)|
|HIV.D.DE455|Serodiscordant partner at ART start|Client living with HIV was in an ongoing sexual relationship with an HIV-negative partner when ART was started|string|[Observation.value[x]](StructureDefinition-hiv-d-de455.html)|
|HIV.D.DE456|Regimen start date|The date on which the client started taking the current ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de456.html)|
|HIV.D.DE459|Dose of medications prescribed|Number of doses (quantity taken at a single point in time) of drugs prescribed/dispensed|string|[Observation.value[x]](StructureDefinition-hiv-d-de459.html)|
|HIV.D.DE46|Date of initiation on ART|The date on which the client was first initiated on ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de46.html)|
|HIV.D.DE460|Number of days medications prescribed|Number of days supply of each medication or regimen prescribed during the visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de460.html)|
|HIV.D.DE461|Medications dispensed|Any other medications that were dispensed to client, including preventive treatment|string|[Observation.value[x]](StructureDefinition-hiv-d-de461.html)|
|HIV.D.DE462|Number of days of medications dispensed|Number of days supply of each medication or regimen dispensed during the visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de462.html)|
|HIV.D.DE463|Dosage|Prescribed dosage of the medication|string|[Observation.value[x]](StructureDefinition-hiv-d-de463.html)|
|HIV.D.DE464|Frequency|Prescribed frequency for taking the medication|string|[Observation.value[x]](StructureDefinition-hiv-d-de464.html)|
|HIV.D.DE466|Type of treatment-limiting toxicity|Type of treatment-limiting toxicity experienced by client. Treatment-limiting toxicity is defined as a serious adverse drug reaction that results in drug discontinuation or substitution. In addition, any reaction that leads to treatment interruption or requires changing the drug or regimen because of an adverse drug reaction is also considered a serious adverse drug reaction.|string|[Observation.value[x]](StructureDefinition-hiv-d-de466.html)|
|HIV.D.DE47|Time on ART|Time the client has been on ART since starting or restarting it in years and months|string|[Observation.value[x]](StructureDefinition-hiv-d-de47.html)|
|HIV.D.DE48|Date(s) ART restarted|Date(s) client restarted ART after stopping (intentionally interrupting) for any number of reasons (see "Reason ART stopped")|string|[Observation.value[x]](StructureDefinition-hiv-d-de48.html)|
|HIV.D.DE480|Unexpected adverse drug reaction (specify)|Specify the type of unexpected adverse drug reaction the client experienced|string|[Observation.value[x]](StructureDefinition-hiv-d-de480.html)|
|HIV.D.DE481|Date(s) of substitution within first-line regimen|Date on which ARV drug regimen (one or more drugs) for client was changed within the first-line regimen (substitution)|string|[Observation.value[x]](StructureDefinition-hiv-d-de481.html)|
|HIV.D.DE482|Reason(s) for substitution within first-line regimen|Reason(s) why one ore more drugs in client's first-line ARV drug regimen was changed (substituted)|string|[Observation.value[x]](StructureDefinition-hiv-d-de482.html)|
|HIV.D.DE483|New antiretroviral regimen after substitution within first-line regimen|New antiretroviral (ARV) drugs after client changed regimen within the first-line regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de483.html)|
|HIV.D.DE484|Date of switch to second-line regimen|Date client was changed from a first-line to second-line ARV drug regimen (switch)|string|[Observation.value[x]](StructureDefinition-hiv-d-de484.html)|
|HIV.D.DE485|New regimen after switch to second-line regimen|New ART regimen after switch to second-line ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de485.html)|
|HIV.D.DE486|Reason for switch to second-line regimen|Reason why client was switched from first- to second-line ARV drug regimen (see "Reason for regimen switch" for levels)|string|[Observation.value[x]](StructureDefinition-hiv-d-de486.html)|
|HIV.D.DE487|Date(s) of substitution within second-line regimen|Date on which ARV drug regimen for client was changed within the second-line regimen (substitution)|string|[Observation.value[x]](StructureDefinition-hiv-d-de487.html)|
|HIV.D.DE488|Reason(s) for substitution within second-line regimen|Reason(s) why client changed drug regimen (within the second-line)|string|[Observation.value[x]](StructureDefinition-hiv-d-de488.html)|
|HIV.D.DE489|New regimen(s) after substitution within second-line regimen|New ARV drugs after client changed regimen within the second- line regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de489.html)|
|HIV.D.DE49|ART cohort|Month and year client originally started ART (documented) at a health facility in the system. The cohort is a group of patients who started ART in the same month (or quarter) and year, whose status is followed over time, using the ART register.|string|[Observation.value[x]](StructureDefinition-hiv-d-de49.html)|
|HIV.D.DE490|Date of switch to third-line regimen|Date client was changed from a second- to third-line ARV drug regimen (switch)|string|[Observation.value[x]](StructureDefinition-hiv-d-de490.html)|
|HIV.D.DE491|New regimen after switch to third-line regimen|New ART regimen after switch to third-line ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de491.html)|
|HIV.D.DE492|Reason for switch to third-line regimen|Reason why client was switched from second- to third-line ARV drug regimen (see "Reason for regimen switch" for levels)|string|[Observation.value[x]](StructureDefinition-hiv-d-de492.html)|
|HIV.D.DE493|Date(s) of substitution within third-line regimen|Date on which ARV drug regimen for client was changed within the third-line (substitution)|string|[Observation.value[x]](StructureDefinition-hiv-d-de493.html)|
|HIV.D.DE494|Reason(s) for substitution within third-line regimen|Reason(s) why client changed drug regimen (within the third-line)|string|[Observation.value[x]](StructureDefinition-hiv-d-de494.html)|
|HIV.D.DE495|New regimen(s) after substitution within third-line regimen|New ARV drugs after client changed regimen within the third-line regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de495.html)|
|HIV.D.DE496|Enhanced adherence counselling provided|Enhanced adherence counselling was provided to the client during the visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de496.html)|
|HIV.D.DE497|First enhanced adherence counselling session completed|A first enhanced adherence counselling was provided to the client during the visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de497.html)|
|HIV.D.DE498|Date of first enhanced adherence counselling session completed|The date on which the first enhanced adherence counselling was provided to the client|string|[Observation.value[x]](StructureDefinition-hiv-d-de498.html)|
|HIV.D.DE499|Second enhanced adherence counselling session completed|A second enhanced adherence counselling was provided to the client during the visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de499.html)|
|HIV.D.DE50|Transfer in for HIV care|Client is transferring in with records or known ART drugs and ART start date|string|[Observation.value[x]](StructureDefinition-hiv-d-de50.html)|
|HIV.D.DE500|Date of second enhanced adherence counselling session completed|The date on which the second enhanced adherence counselling was provided to the client|string|[Observation.value[x]](StructureDefinition-hiv-d-de500.html)|
|HIV.D.DE501|Third enhanced adherence counselling session completed|A third enhanced adherence counselling was provided to the client during the visit|string|[Observation.value[x]](StructureDefinition-hiv-d-de501.html)|
|HIV.D.DE502|Date of third enhanced adherence counselling session completed|The date on which the third enhanced adherence counselling was provided to the client|string|[Observation.value[x]](StructureDefinition-hiv-d-de502.html)|
|HIV.D.DE503|Name of treatment supporter|Full name of person providing support to client for adherence, care, treatment and other needs (e.g. ARV pick-up if ill)|string|[Observation.value[x]](StructureDefinition-hiv-d-de503.html)|
|HIV.D.DE504|Address of treatment supporter|Full address or description of home of treatment supporter|string|[Observation.value[x]](StructureDefinition-hiv-d-de504.html)|
|HIV.D.DE505|Telephone number of treatment supporter|Telephone number if available, or else telephone number of neighbour/friend|string|[Observation.value[x]](StructureDefinition-hiv-d-de505.html)|
|HIV.D.DE506|Home-based care provider|Name of individual or organization that provides home-based care to client|string|[Observation.value[x]](StructureDefinition-hiv-d-de506.html)|
|HIV.D.DE507|Counselling provided on diagnoses|Counselling provided on diagnoses|string|[Observation.value[x]](StructureDefinition-hiv-d-de507.html)|
|HIV.D.DE508|Hepatitis B positive counselling conducted|Whether counselling was provided to a client who has been diagnosed with hepatitis B|string|[Observation.value[x]](StructureDefinition-hiv-d-de508.html)|
|HIV.D.DE509|Hepatitis C positive counselling conducted|Whether counselling was provided to a client who has been diagnosed with hepatitis C|string|[Observation.value[x]](StructureDefinition-hiv-d-de509.html)|
|HIV.D.DE51|Date of transfer in|Date client presented at facility (with transfer/referral slip) from another facility (and on ART) within the system|string|[Observation.value[x]](StructureDefinition-hiv-d-de51.html)|
|HIV.D.DE510|Syphilis counselling and treatment|Whether counselling and treatment was provided to a client who has been diagnosed with syphilis|string|[Observation.value[x]](StructureDefinition-hiv-d-de510.html)|
|HIV.D.DE511|Syphilis counselling, treatment and further testing|Whether counselling and treatment was provided to a client who has been diagnosed with syphilis. Additional testing (RPR test) recommended.|string|[Observation.value[x]](StructureDefinition-hiv-d-de511.html)|
|HIV.D.DE512|Accepted partner services|Client accepted offer for partner services|string|[Observation.value[x]](StructureDefinition-hiv-d-de512.html)|
|HIV.D.DE514|HIV status of family member|HIV status of each family member at time of patient's enrolment, including partner (for mothers)|string|[Observation.value[x]](StructureDefinition-hiv-d-de514.html)|
|HIV.D.DE515|Unique ID of family member|Unique ID number of each family member if enrolled in HIV care according to national guidelines (see unique ID number)|string|[Observation.value[x]](StructureDefinition-hiv-d-de515.html)|
|HIV.D.DE516|Date of death of family member|Date of death for each family member as appropriate|string|[Observation.value[x]](StructureDefinition-hiv-d-de516.html)|
|HIV.D.DE518|Provided support for disclosure and partner services|Offer or refer for support for disclosure and partner services|string|[Observation.value[x]](StructureDefinition-hiv-d-de518.html)|
|HIV.D.DE52|Facility transferred from|Name of health facility client was transferred from|string|[Observation.value[x]](StructureDefinition-hiv-d-de52.html)|
|HIV.D.DE53|Date enrolled in HIV care|Date client first enrols in HIV care at the facility. Begins when a person with a confirmed HIV diagnosis presents to a facility where HIV care is provided and a medical record, patient card, file or chart is opened for the first time. This could be at an HIV care/ART, MNCH or TB clinic.|string|[Observation.value[x]](StructureDefinition-hiv-d-de53.html)|
|HIV.D.DE531|Follow-up test recommended date|A test or screening recommended for the client's care plan at a future date|string|[Observation.value[x]](StructureDefinition-hiv-d-de531.html)|
|HIV.D.DE532|Reason blood pressure reading not done|Reason why test was not performed|string|[Observation.value[x]](StructureDefinition-hiv-d-de532.html)|
|HIV.D.DE535|Other|Other reason blood pressure can not be taken|string|[Observation.value[x]](StructureDefinition-hiv-d-de535.html)|
|HIV.D.DE537|Current medications|List of all of the medications the client is currently taking|string|[Observation.value[x]](StructureDefinition-hiv-d-de537.html)|
|HIV.D.DE54|Age at enrolment|Client's age when the client was enrolled in ART care|string|[Observation.value[x]](StructureDefinition-hiv-d-de54.html)|
|HIV.D.DE55|Facility where client first enrolled in HIV care|Facility where the client first enrolled in HIV care|string|[Observation.value[x]](StructureDefinition-hiv-d-de55.html)|
|HIV.D.DE559|Other medications (specify)|Other medications or supplements that are not listed above (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de559.html)|
|HIV.D.DE56|Antiretroviral (ARV) drugs received prior to enrolment|Whether or not the client received ARV drugs prior to enrolling into HIV care|string|[Observation.value[x]](StructureDefinition-hiv-d-de56.html)|
|HIV.D.DE560|Allergies|Does the client have any allergies?|string|[Observation.value[x]](StructureDefinition-hiv-d-de560.html)|
|HIV.D.DE568|Other allergies (specify)|Client has other allergies not listed here (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de568.html)|
|HIV.D.DE569|Family planning method used|Method the client reports currently using at intake|string|[Observation.value[x]](StructureDefinition-hiv-d-de569.html)|
|HIV.D.DE593|Medication status|Current state of the client's taking of the medication|string|[Observation.value[x]](StructureDefinition-hiv-d-de593.html)|
|HIV.D.DE602|Hepatitis B negative counselling conducted|Hepatitis B negative counselling conducted|string|[Observation.value[x]](StructureDefinition-hiv-d-de602.html)|
|HIV.D.DE603|Vaccine brand|The brand or trade name used to refer to the vaccine received|string|[Observation.value[x]](StructureDefinition-hiv-d-de603.html)|
|HIV.D.DE604|Vaccine type|Type of vaccine received (such as IPV, OPV)|string|[Observation.value[x]](StructureDefinition-hiv-d-de604.html)|
|HIV.D.DE605|Date and time of vaccination|Represents the visit/encounter date, which is the date and time when the vaccine was administered to the client|string|[Observation.value[x]](StructureDefinition-hiv-d-de605.html)|
|HIV.D.DE606|Vaccination location|The service delivery location where the vaccine adminstration occurred|string|[Observation.value[x]](StructureDefinition-hiv-d-de606.html)|
|HIV.D.DE607|Dose number|Vaccine dose number within series|string|[Observation.value[x]](StructureDefinition-hiv-d-de607.html)|
|HIV.D.DE608|Dose quantity|The quantity of vaccine product that was administered|string|[Observation.value[x]](StructureDefinition-hiv-d-de608.html)|
|HIV.D.DE609|Total doses in series|The recommended number of vaccine doses for immunity according to national protocol|string|[Observation.value[x]](StructureDefinition-hiv-d-de609.html)|
|HIV.D.DE610|Disease targeted|Vaccine preventable disease being targeted by vaccine administered|string|[Observation.value[x]](StructureDefinition-hiv-d-de610.html)|
|HIV.D.DE62|Date ARV drugs received prior to enrolment|Date ARV drugs were started prior to enrolment into HIV care/ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de62.html)|
|HIV.D.DE63|Location ARV drugs received prior to enrolment|Health facility (or other location) where ARV drugs were received prior to enrolment into HIV care/ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de63.html)|
|HIV.D.DE636|Reason immunization was not provided|Reason the vaccine dose was not given|string|[Observation.value[x]](StructureDefinition-hiv-d-de636.html)|
|HIV.D.DE64|ARV drug regimen received prior to enrolment|ARV drug regimen received prior to enrolment into HIV care/ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de64.html)|
|HIV.D.DE642|Other reason immunization not provided (specify)|Other reason why the immunization was not provided (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de642.html)|
|HIV.D.DE643|Malaria prophylaxis|Whether malaria prophylaxis was given|string|[Observation.value[x]](StructureDefinition-hiv-d-de643.html)|
|HIV.D.DE644|IPTp-SP dose number provided|IPTp-SP dose number that was provided|string|[Observation.value[x]](StructureDefinition-hiv-d-de644.html)|
|HIV.D.DE645|Date IPTp-SP dose provided|Date on which the IPTp-SP dose was provided|string|[Observation.value[x]](StructureDefinition-hiv-d-de645.html)|
|HIV.D.DE646|Reason malaria prophylaxis not provided|Reason why the treatment was not given|string|[Observation.value[x]](StructureDefinition-hiv-d-de646.html)|
|HIV.D.DE65|Existing chronic health conditions|Does the client have any current chronic health conditions or problems?|string|[Observation.value[x]](StructureDefinition-hiv-d-de65.html)|
|HIV.D.DE651|Other reason not provided (specify)|Other reason why the prophylaxis was not provided|string|[Observation.value[x]](StructureDefinition-hiv-d-de651.html)|
|HIV.D.DE652|>28 days since last missed appointment|More than 28 days have passed since client's last missed appointment|string|[Observation.value[x]](StructureDefinition-hiv-d-de652.html)|
|HIV.D.DE653|AIDS-related death|Death of client was AIDS-related|string|[Observation.value[x]](StructureDefinition-hiv-d-de653.html)|
|HIV.D.DE654|Date of first AIDS diagnosis|Date of client's first AIDS diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-d-de654.html)|
|HIV.D.DE655|Age at final HPV vaccination dose received|Client's age at date received final HPV vaccination dose|string|[Observation.value[x]](StructureDefinition-hiv-d-de655.html)|
|HIV.D.DE656|Date of cervical cancer screening test|Date of cervical cancer screening test|string|[Observation.value[x]](StructureDefinition-hiv-d-de656.html)|
|HIV.D.DE657|Lifetime screening test number|Client's lifetime number of screenings for cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de657.html)|
|HIV.D.DE658|Cervical cancer primary screening test type|Type of cervical cancer screening test used in primary screening|string|[Observation.value[x]](StructureDefinition-hiv-d-de658.html)|
|HIV.D.DE664|HPV-DNA cervical cancer screening test result|HPV-DNA cervical cancer screening test result|string|[Observation.value[x]](StructureDefinition-hiv-d-de664.html)|
|HIV.D.DE668|VIA cervical cancer screening test result|Screening test result for VIA|string|[Observation.value[x]](StructureDefinition-hiv-d-de668.html)|
|HIV.D.DE673|Cervical cytology screening test result|Screening result for cervical cytology|string|[Observation.value[x]](StructureDefinition-hiv-d-de673.html)|
|HIV.D.DE680|Cervical cancer triage test date|Date of triage test for cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de680.html)|
|HIV.D.DE681|Cervical cancer triage test type|Type of triage test for cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de681.html)|
|HIV.D.DE688|HPV16/18 test result|Test result from HPV16/18 test|string|[Observation.value[x]](StructureDefinition-hiv-d-de688.html)|
|HIV.D.DE691|Cervical cancer colposcopy result|Result of cervical cancer colposcopy|string|[Observation.value[x]](StructureDefinition-hiv-d-de691.html)|
|HIV.D.DE697|Cervical cancer histopathology result|Result of cervical cancer histopathology|string|[Observation.value[x]](StructureDefinition-hiv-d-de697.html)|
|HIV.D.DE702|Date of additional cervical cancer triage test|Date of tertiary cervical cancer screening test|string|[Observation.value[x]](StructureDefinition-hiv-d-de702.html)|
|HIV.D.DE703|Additional cervical cancer triage test type (specify)|Additional cervical cancer triage test type (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de703.html)|
|HIV.D.DE704|Additional cervical cancer triage test result (specify)|Additional cervical cancer triage test result (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de704.html)|
|HIV.D.DE705|Date of diagnosis of cervical precancer lesions or invasive cervical cancer|Date of diagnosis of cervical precancer lesions or invasive cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de705.html)|
|HIV.D.DE706|Cervical cancer screening outcome|Client's screening outcome for cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de706.html)|
|HIV.D.DE709|Cervical cancer diagnosis|Type of cervical cancer diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-d-de709.html)|
|HIV.D.DE712|Cervical cancer stage at diagnosis|Cervical cancer stage at diagnosis of cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de712.html)|
|HIV.D.DE718|Date of treatment for cervical precancer lesions|Date of treatment for cervical precancer lesions|string|[Observation.value[x]](StructureDefinition-hiv-d-de718.html)|
|HIV.D.DE719|Treatment method for cervical precancer lesions|Treatment method for cervical precancer lesions|string|[Observation.value[x]](StructureDefinition-hiv-d-de719.html)|
|HIV.D.DE728|Date of follow-up for treatment for cervical precancer lesions|Date of follow-up for treatment for cervical precancer lesions|string|[Observation.value[x]](StructureDefinition-hiv-d-de728.html)|
|HIV.D.DE729|Date of start of invasive cancer treatment|Date of start of invasive cancer treatment|string|[Observation.value[x]](StructureDefinition-hiv-d-de729.html)|
|HIV.D.DE730|Invasive cervical cancer treatment episode|Client's lifetime number of treatments for invasive cervical cancer|string|[Observation.value[x]](StructureDefinition-hiv-d-de730.html)|
|HIV.D.DE731|Invasive cervical cancer treatment method|Invasive cervical cancer treatment method|string|[Observation.value[x]](StructureDefinition-hiv-d-de731.html)|
|HIV.D.DE74|Original first-line ART regimen|Original full, first-line ARV drug regimen patient started on at this facility|string|[Observation.value[x]](StructureDefinition-hiv-d-de74.html)|
|HIV.D.DE741|Treatment outcome|Treatment outcome from cervical pre-cancerous lesion treatment or invasive cancer treatment (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de741.html)|
|HIV.D.DE742|Secondary/other cancers diagnosed|Secondary and other cancers that client is diagnosed with (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de742.html)|
|HIV.D.DE743|Cancers at other sites (HPV- and non-HPV related)|Cancers at other sites that client has (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de743.html)|
|HIV.D.DE744|Date of death|If deceased, the date that the client died|string|[Observation.value[x]](StructureDefinition-hiv-d-de744.html)|
|HIV.D.DE745|Cervical cancer screening interval amongst WLHIV|Country-specific interval between cancer screenings amongst women living with HIV (typically 3 or 5 years)|string|[Observation.value[x]](StructureDefinition-hiv-d-de745.html)|
|HIV.D.DE75|Current ART regimen|The current ART regimen the client is taking|string|[Observation.value[x]](StructureDefinition-hiv-d-de75.html)|
|HIV.D.DE76|Current ART regimen start date|The date on which the client started taking the current ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de76.html)|
|HIV.D.DE760|Eligible for DSD ART|Client is eligible for differentiated service delivery (DSD) for ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de760.html)|
|HIV.D.DE761|Date DSD ART eligibility assessed|Date client was assessed for eligibility for differentiated service delivery (DSD) for ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de761.html)|
|HIV.D.DE762|Currently enrolled in DSD ART model|Client currently enrolled in differentiated service delivery (DSD) ART model|string|[Observation.value[x]](StructureDefinition-hiv-d-de762.html)|
|HIV.D.DE763|DSD ART start date|Date client started on differentiated service delivery (DSD) for ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de763.html)|
|HIV.D.DE764|DSD ART model(s)|Type of DSD ART model client is enrolled in (country-specific)|string|[Observation.value[x]](StructureDefinition-hiv-d-de764.html)|
|HIV.D.DE77|Preferred first-line ART regimen|The preferred first-line ART regimen for the client according to WHO (or national) guidelines|string|[Observation.value[x]](StructureDefinition-hiv-d-de77.html)|
|HIV.D.DE771|Other DSD ART model (specify)|Client is enrolled in another DSD ART model (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de771.html)|
|HIV.D.DE772|Partner testing offered|Whether client was offered partner testing|string|[Observation.value[x]](StructureDefinition-hiv-d-de772.html)|
|HIV.D.DE773|Partner testing accepted|Whether partner testing was accepted|string|[Observation.value[x]](StructureDefinition-hiv-d-de773.html)|
|HIV.D.DE774|Date partner contacted for index testing|Date on which client's partner was contacted for index testing|string|[Observation.value[x]](StructureDefinition-hiv-d-de774.html)|
|HIV.D.DE775|Date partner tested for HIV|Date on which client's partner was tested for HIV|string|[Observation.value[x]](StructureDefinition-hiv-d-de775.html)|
|HIV.D.DE776|Date of next scheduled follow-up appointment|Date of client's next scheduled follow-up appointment|string|[Observation.value[x]](StructureDefinition-hiv-d-de776.html)|
|HIV.D.DE777|Type of next follow-up appointment|Type of client's next follow-up appointment (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de777.html)|
|HIV.D.DE78|Alternative first-line ART regimen|The alternative first-line ART regimen for the client according to WHO (or national) guidelines|string|[Observation.value[x]](StructureDefinition-hiv-d-de78.html)|
|HIV.D.DE79|First-line ART regimen under special circumstances|The first-line ART regimen for the client under special circumstances according to WHO (or national) guidelines|string|[Observation.value[x]](StructureDefinition-hiv-d-de79.html)|
|HIV.D.DE8|Scheduled visit|Is this is a scheduled visit?|string|[Observation.value[x]](StructureDefinition-hiv-d-de8.html)|
|HIV.D.DE80|Preferred second-line ART regimen|The preferred second-line ART regimen for the client according to WHO (or national) guidelines|string|[Observation.value[x]](StructureDefinition-hiv-d-de80.html)|
|HIV.D.DE81|Alternative second-line ART regimen|The alternative second-line ART regimen for the client according to WHO (or national) guidelines|string|[Observation.value[x]](StructureDefinition-hiv-d-de81.html)|
|HIV.D.DE82|Optimal regimen for transition|The optimal regimen for transition to DTG-based regimens for children established on ART|string|[Observation.value[x]](StructureDefinition-hiv-d-de82.html)|
|HIV.D.DE83|Current ART regimen (first-, second-, or third-line)|ART regimen for treating clients living with HIV, based on national guidance|string|[Observation.value[x]](StructureDefinition-hiv-d-de83.html)|
|HIV.D.DE884|Mid-upper arm circumference (MUAC)|Client's mid-upper arm circumference (MUAC)|string|[Observation.value[x]](StructureDefinition-hiv-d-de884.html)|
|HIV.D.DE885|Date of start of fluconazole prophylaxis|Date of client's start of fluconazole prophylaxis|string|[Observation.value[x]](StructureDefinition-hiv-d-de885.html)|
|HIV.D.DE886|Fluconazole prophylaxis|Client provided with fluconazole prophylaxis|string|[Observation.value[x]](StructureDefinition-hiv-d-de886.html)|
|HIV.D.DE887|Date started cryptococcal meningitis treatment induction regimen|Date client started cryptococcal meningitis treatment induction regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de887.html)|
|HIV.D.DE888|Date completed cryptococcal meningitis treatment induction regimen|Date client completed cryptococcal meningitis treatment induction regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de888.html)|
|HIV.D.DE889|Date started cryptococcal meningitis treatment maintenance regimen|Date client started cryptococcal meningitis treatment maintenance regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de889.html)|
|HIV.D.DE890|Date completed cryptococcal meningitis treatment maintenance regimen|Date client completed cryptococcal meningitis treatment maintenance regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de890.html)|
|HIV.D.DE891|Date started cryptococcal meningitis treatment consolidation regimen|Date client started cryptococcal meningitis treatment consolidation regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de891.html)|
|HIV.D.DE892|Date completed cryptococcal meningitis treatment consolidation regimen|Date client completed cryptococcal meningitis treatment consolidation regimen|string|[Observation.value[x]](StructureDefinition-hiv-d-de892.html)|
|HIV.D.DE893|Staging of liver disease|Staging of liver disease in client|string|[Observation.value[x]](StructureDefinition-hiv-d-de893.html)|
|HIV.D.DE896|Advanced HIV disease|Client has Advanced HIV disease (AHD)|string|[Observation.value[x]](StructureDefinition-hiv-d-de896.html)|
|HIV.D.DE897|WHO functional status|Functional status of people with advanced HIV disease|string|[Observation.value[x]](StructureDefinition-hiv-d-de897.html)|
|HIV.D.DE9|Body temperature|Temperature of the client in Celsius|string|[Observation.value[x]](StructureDefinition-hiv-d-de9.html)|
|HIV.D.DE90|ART regimen|List of ART regimens|string|[Observation.value[x]](StructureDefinition-hiv-d-de90.html)|
|HIV.D.DE901|Tailored adherence counselling for advanced HIV disease|Client provided with tailored adherence counselling for advanced HIV disease|string|[Observation.value[x]](StructureDefinition-hiv-d-de901.html)|
|HIV.D.DE902|Date(s) of tracing interventions|Date tracing interventions to support reengagement into HIV care conducted|string|[Observation.value[x]](StructureDefinition-hiv-d-de902.html)|
|HIV.D.DE903|Medication/drug|Current or considered medication/drug, for the purpose of determining drug interactions|string|[Observation.value[x]](StructureDefinition-hiv-d-de903.html)|
|HIV.D.DE933|Medication change recommended|A medication change is recommended for the client based upon current or considered medications|string|[Observation.value[x]](StructureDefinition-hiv-d-de933.html)|
|HIV.D.DE938|TB disease|Whether the client has tuberculosis (TB) disease. Sometimes known as active TB|string|[Observation.value[x]](StructureDefinition-hiv-d-de938.html)|
|HIV.D.DE939|TB diagnosis result|Final result of the TB investigation (bacteriological and/or clinical)|string|[Observation.value[x]](StructureDefinition-hiv-d-de939.html)|
|HIV.D.DE942|Method of TB diagnosis|Method used to set the TB diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-d-de942.html)|
|HIV.D.DE945|Presumptive TB|Client has signs or symptoms of tuberculosis (TB) without laboratory confirmation|string|[Observation.value[x]](StructureDefinition-hiv-d-de945.html)|
|HIV.D.DE946|Presumptive TB registration date|Date client is registered as having signs or symptoms of tuberculosis (TB) without laboratory confirmation|string|[Observation.value[x]](StructureDefinition-hiv-d-de946.html)|
|HIV.D.DE947|TB treatment history|History of previous TB treatment|string|[Observation.value[x]](StructureDefinition-hiv-d-de947.html)|
|HIV.D.DE952|Date of TB diagnosis|The date when the diagnosis was established|string|[Observation.value[x]](StructureDefinition-hiv-d-de952.html)|
|HIV.D.DE953|Currently on TB preventive treatment (TPT)|Client is currently taking TPT|string|[Observation.value[x]](StructureDefinition-hiv-d-de953.html)|
|HIV.D.DE954|TB preventive treatment (TPT) start date|The date on which the client began taking TPT|string|[Observation.value[x]](StructureDefinition-hiv-d-de954.html)|
|HIV.D.DE955|TB preventive treatment (TPT) completion date|The date on which the client completed TPT|string|[Observation.value[x]](StructureDefinition-hiv-d-de955.html)|
|HIV.D.DE956|TB screening algorithm|Screening algorithm selected for screening activities|string|[Observation.value[x]](StructureDefinition-hiv-d-de956.html)|
|HIV.D.DE971|Other TB screening algorithm (specify)|Client screened for tuberculosis (TB) with a different screening method not listed (specify)|string|[Observation.value[x]](StructureDefinition-hiv-d-de971.html)|
|HIV.D.DE972|TB screening conducted|A screening for tuberculosis (TB) was performed|string|[Observation.value[x]](StructureDefinition-hiv-d-de972.html)|
|HIV.D.DE973|Symptoms of TB|Symptoms that may indicate TB disease in clients living with HIV, based on a clinical algorithm|string|[Observation.value[x]](StructureDefinition-hiv-d-de973.html)|
|HIV.D.DE985|History of contact with a person with TB|Client had a history of a contact with a person with TB|string|[Observation.value[x]](StructureDefinition-hiv-d-de985.html)|
|HIV.D.DE986|TB screening result|Record the result of the tuberculosis (TB) screening|string|[Observation.value[x]](StructureDefinition-hiv-d-de986.html)|
|HIV.D.DE990|TB screening date|Date the TB screening was conducted|string|[Observation.value[x]](StructureDefinition-hiv-d-de990.html)|
|HIV.D.DE991|TB screening result date|The date when the result of TB screening is available|string|[Observation.value[x]](StructureDefinition-hiv-d-de991.html)|
|HIV.D.DE992|TB diagnostic test category|The type of diagnostic test performed to detect tuberculosis (TB) disease|string|[Observation.value[x]](StructureDefinition-hiv-d-de992.html)|
|HIV.D.DE997|TB diagnostic test date|The date when TB diagnostic test was performed|string|[Observation.value[x]](StructureDefinition-hiv-d-de997.html)|
|HIV.D.DE998|Test sample collection date|The date when the test sample was collected from the client|string|[Observation.value[x]](StructureDefinition-hiv-d-de998.html)|
|HIV.D.DE999|TB diagnostic test result date|The date when the result of the TB diagnostic test is available|string|[Observation.value[x]](StructureDefinition-hiv-d-de999.html)|
|HIV.E.DE1|Pregnant woman's first name|Pregnant woman's first or given name|string|[Observation.value[x]](StructureDefinition-hiv-e-de1.html)|
|HIV.E.DE100|Head circumference|Head circumference of infant at birth in cm|string|[Observation.value[x]](StructureDefinition-hiv-e-de100.html)|
|HIV.E.DE101|Mother HIV test conducted|Whether an HIV test of the mother was conducted|string|[Observation.value[x]](StructureDefinition-hiv-e-de101.html)|
|HIV.E.DE102|Mother HIV test ordered|Whether an HIV test of the mother was ordered|string|[Observation.value[x]](StructureDefinition-hiv-e-de102.html)|
|HIV.E.DE103|Mother HIV test date|Date when a mother's HIV test was conducted|string|[Observation.value[x]](StructureDefinition-hiv-e-de103.html)|
|HIV.E.DE104|Maternal HIV test result|Test result for mother after applying the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-e-de104.html)|
|HIV.E.DE108|Infant or child exposure to HIV|Whether the infant or child was determined to have had HIV exposure through mother|string|[Observation.value[x]](StructureDefinition-hiv-e-de108.html)|
|HIV.E.DE112|HIV-exposed infant or child|Whether the infant or child was determined to have had HIV exposure|string|[Observation.value[x]](StructureDefinition-hiv-e-de112.html)|
|HIV.E.DE119|Postpartum family planning counselling conducted|Provide family planning and contraception counselling|string|[Observation.value[x]](StructureDefinition-hiv-e-de119.html)|
|HIV.E.DE12|Number of previous pregnancies|This calculates the total number of all previous pregnancies (i.e. not including this current pregnancy). This is done for easier obstetric history calculations.|string|[Observation.value[x]](StructureDefinition-hiv-e-de12.html)|
|HIV.E.DE120|Age of infant on HIV test date|Infant's age when an HIV test is performed in months and years (calculated from date of birth)|string|[Observation.value[x]](StructureDefinition-hiv-e-de120.html)|
|HIV.E.DE121|ARV adherence counselling|Counselling was carried out during visit|string|[Observation.value[x]](StructureDefinition-hiv-e-de121.html)|
|HIV.E.DE122|Infant feeding counselling provided|Support on infant and child feeding to mother or caregiver provided|string|[Observation.value[x]](StructureDefinition-hiv-e-de122.html)|
|HIV.E.DE123|Date infant feeding counselling provided|Date support on infant and child feeding to mother or caregiver provided|string|[Observation.value[x]](StructureDefinition-hiv-e-de123.html)|
|HIV.E.DE124|Malaria prevention counselling conducted|Counselling provided on how to prevent malaria|string|[Observation.value[x]](StructureDefinition-hiv-e-de124.html)|
|HIV.E.DE125|Insecticide treated bednet (ITN) provided or referred|An insecticide treated bednet (ITN) was provided or the client was referred|string|[Observation.value[x]](StructureDefinition-hiv-e-de125.html)|
|HIV.E.DE126|Maternal syphilis treatment|Whether or not mother was treated for syphilis|string|[Observation.value[x]](StructureDefinition-hiv-e-de126.html)|
|HIV.E.DE127|Infant feeding practice|Infant feeding practice|string|[Observation.value[x]](StructureDefinition-hiv-e-de127.html)|
|HIV.E.DE131|Infant feeding practice recorded date|Date on which infant feeding practice was recorded|string|[Observation.value[x]](StructureDefinition-hiv-e-de131.html)|
|HIV.E.DE132|Stopped breastfeeding|The mother has fully stopped breastfeeding the infant or child|string|[Observation.value[x]](StructureDefinition-hiv-e-de132.html)|
|HIV.E.DE133|Date stopped breastfeeding|The date on which the mother stopped breastfeeding the infant|string|[Observation.value[x]](StructureDefinition-hiv-e-de133.html)|
|HIV.E.DE134|Taking iron and folic acid (IFA) tablets|Is client taking her iron and folic acid (IFA) tablets? Select whether the woman is continuing to take IFA supplements|string|[Observation.value[x]](StructureDefinition-hiv-e-de134.html)|
|HIV.E.DE135|Amount of iron prescribed|Amount of iron supplements prescribed in milligrams for intake|string|[Observation.value[x]](StructureDefinition-hiv-e-de135.html)|
|HIV.E.DE136|Type of iron supplement dosage provided|Whether the amount of iron prescribed is for daily or weekly intake|string|[Observation.value[x]](StructureDefinition-hiv-e-de136.html)|
|HIV.E.DE139|Amount of daily dose of folic acid prescribed|Amount of folic acid supplements prescribed in milligrams for daily intake|string|[Observation.value[x]](StructureDefinition-hiv-e-de139.html)|
|HIV.E.DE140|Date infant ARV prophylaxis dispensed (or started)|Date HIV-exposed infant received ARV prophylaxis (for the first time)|string|[Observation.value[x]](StructureDefinition-hiv-e-de140.html)|
|HIV.E.DE141|Maternal HIV status|The HIV status of the infant's mother|string|[Observation.value[x]](StructureDefinition-hiv-e-de141.html)|
|HIV.E.DE145|Maternal HIV status at first ANC visit|The HIV status of the infant's mother at first ANC visit|string|[Observation.value[x]](StructureDefinition-hiv-e-de145.html)|
|HIV.E.DE149|Maternal syphilis test result|Result from maternal syphilis test|string|[Observation.value[x]](StructureDefinition-hiv-e-de149.html)|
|HIV.E.DE15|Number of caesarian sections|Total number of caesarean sections|string|[Observation.value[x]](StructureDefinition-hiv-e-de15.html)|
|HIV.E.DE153|Hypertension|Whether the client has developed hypertension associated with pregnancy|string|[Observation.value[x]](StructureDefinition-hiv-e-de153.html)|
|HIV.E.DE154|Pre-eclampsia|Whether the client has pre-eclampsia|string|[Observation.value[x]](StructureDefinition-hiv-e-de154.html)|
|HIV.E.DE16|Number of stillbirths|Total number of stillbirths after 22 weeks|string|[Observation.value[x]](StructureDefinition-hiv-e-de16.html)|
|HIV.E.DE161|Date woman received counselling for CPT|Date woman received counselling for co-trimoxazole preventive therapy (CPT)|string|[Observation.value[x]](StructureDefinition-hiv-e-de161.html)|
|HIV.E.DE162|Date woman received counselling for TPT|Date woman received counselling for TB preventive therapy|string|[Observation.value[x]](StructureDefinition-hiv-e-de162.html)|
|HIV.E.DE163|Infant's co-trimoxazole prophylaxis start date|Start date of co-trimoxazole prophylaxis|string|[Observation.value[x]](StructureDefinition-hiv-e-de163.html)|
|HIV.E.DE164|Infant's age when co-trimoxazole prophylaxis was started|The number of weeks or months infant was when started on co-trimoxazole (CTX) prophylaxis preventive therapy|string|[Observation.value[x]](StructureDefinition-hiv-e-de164.html)|
|HIV.E.DE165|Presumptive clinical diagnosis of severe HIV infection in infants|Presumptive clinical diagnosis of severe HIV infection in infants|string|[Observation.value[x]](StructureDefinition-hiv-e-de165.html)|
|HIV.E.DE166|Infant ARV prophylaxis|Infant is taking an antiretroviral prophylaxis to prevent infection from HIV exposure|string|[Observation.value[x]](StructureDefinition-hiv-e-de166.html)|
|HIV.E.DE167|Infant ARV prophylaxis start date|The date on which the infant was started on an antiretroviral prophylaxis|string|[Observation.value[x]](StructureDefinition-hiv-e-de167.html)|
|HIV.E.DE17|Past pregnancy complications|Whether the woman has had any complications or problems in any previous pregnancy|string|[Observation.value[x]](StructureDefinition-hiv-e-de17.html)|
|HIV.E.DE173|Maternal and child health service visit|Maternal and child health service visit attended by an HIV-exposed infant|string|[Observation.value[x]](StructureDefinition-hiv-e-de173.html)|
|HIV.E.DE177|Weeks postpartum|Number of weeks postpartum on this visit date|string|[Observation.value[x]](StructureDefinition-hiv-e-de177.html)|
|HIV.E.DE178|Birth cohort|Month and year of infant's birth, which the infant is registered into. The cohort is a group of infants born in the same month, whose status is followed over time.|string|[Observation.value[x]](StructureDefinition-hiv-e-de178.html)|
|HIV.E.DE179|Registered in birth cohort|Whether the infant has been registered in a birth cohort|string|[Observation.value[x]](StructureDefinition-hiv-e-de179.html)|
|HIV.E.DE180|EID sample number|Early infant diagnosis (EID) sample number|string|[Observation.value[x]](StructureDefinition-hiv-e-de180.html)|
|HIV.E.DE181|EID sample 1|First sample used to test an infant for HIV|string|[Observation.value[x]](StructureDefinition-hiv-e-de181.html)|
|HIV.E.DE182|EID sample 2|Second sample used to test an infant for HIV|string|[Observation.value[x]](StructureDefinition-hiv-e-de182.html)|
|HIV.E.DE183|EID test number|Early infant diagnosis (EID) HIV test number using the same sample|string|[Observation.value[x]](StructureDefinition-hiv-e-de183.html)|
|HIV.E.DE184|EID test number 1|First test on a sample to test an infant for HIV|string|[Observation.value[x]](StructureDefinition-hiv-e-de184.html)|
|HIV.E.DE185|EID test number 2|Second test on a sample to test an infant for HIV|string|[Observation.value[x]](StructureDefinition-hiv-e-de185.html)|
|HIV.E.DE186|EID test number 1 test result|Early infant diagnosis test number 1 test result|string|[Observation.value[x]](StructureDefinition-hiv-e-de186.html)|
|HIV.E.DE190|EID test number 2 test result|Early infant diagnosis test number 2 test result|string|[Observation.value[x]](StructureDefinition-hiv-e-de190.html)|
|HIV.E.DE2|Pregnant woman's surname|Pregnant woman's family name or last name|string|[Observation.value[x]](StructureDefinition-hiv-e-de2.html)|
|HIV.E.DE216|Test result of syphilis assay 1|The result of the first syphilis assay in the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-e-de216.html)|
|HIV.E.DE220|Test result of syphilis assay 1 repeated|The result of the first syphilis assay repeated in the testing strategy|string|[Observation.value[x]](StructureDefinition-hiv-e-de220.html)|
|HIV.E.DE225|Infant HIV status|HIV status reported after applying the HIV testing algorithm. No single HIV test can provide an HIV-positive diagnosis.|string|[Observation.value[x]](StructureDefinition-hiv-e-de225.html)|
|HIV.E.DE229|Infant ART start date|The date on which the infant was started or restarted on antiretroviral therapy (ART)|string|[Observation.value[x]](StructureDefinition-hiv-e-de229.html)|
|HIV.E.DE230|Final diagnosis of HIV-exposed infant|HIV-exposed infant final status at 18 months or 3 months after cessation of breastfeeding (whichever is later).|string|[Observation.value[x]](StructureDefinition-hiv-e-de230.html)|
|HIV.E.DE234|HIV-exposed infant reason for unknown final status|The outcome for the infant does not have a final outcome, which may because of death, stopped treatment or lost to follow-up.|string|[Observation.value[x]](StructureDefinition-hiv-e-de234.html)|
|HIV.E.DE239|Date of death of infant|Date that the infant died|string|[Observation.value[x]](StructureDefinition-hiv-e-de239.html)|
|HIV.E.DE240|Cause of death of infant|The infant's cause of death|string|[Observation.value[x]](StructureDefinition-hiv-e-de240.html)|
|HIV.E.DE241|Infant died within 24 hours of childbirth|The infant died within 24 hours of childbirth|string|[Observation.value[x]](StructureDefinition-hiv-e-de241.html)|
|HIV.E.DE242|Action(s) needed during infant follow-up visit|Any actions needed during infant follow-up visit|string|[Observation.value[x]](StructureDefinition-hiv-e-de242.html)|
|HIV.E.DE243|Timing of additional infant HIV test|Age in months when additional infant HIV test is performed|string|[Observation.value[x]](StructureDefinition-hiv-e-de243.html)|
|HIV.E.DE244|Date of sample collection of additional infant HIV test|Date of sample collection of additional infant HIV test|string|[Observation.value[x]](StructureDefinition-hiv-e-de244.html)|
|HIV.E.DE245|Haemoglobin (Hb) result|Result of woman's haemoglobin test during ANC, labour or delivery. Full blood count testing is recommended, and if not available, use of  haemoglobinometer over haemoglobin colour scale.|string|[Observation.value[x]](StructureDefinition-hiv-e-de245.html)|
|HIV.E.DE246|Blood group and Rh factor|Mother's blood type and blood Rh factor|string|[Observation.value[x]](StructureDefinition-hiv-e-de246.html)|
|HIV.E.DE255|Asymptomatic bacteriuria (ASB) test result|Result of urine culture (or urine Gram-staining if not available over dipstick tests) for diagnosing asymptomatic bacteriuria|string|[Observation.value[x]](StructureDefinition-hiv-e-de255.html)|
|HIV.E.DE259|Urine protein test result|Results of urine protein test of mother during ANC visit|string|[Observation.value[x]](StructureDefinition-hiv-e-de259.html)|
|HIV.E.DE264|Type of hypertensive disorder|Type of hypertensive disorder of the mother|string|[Observation.value[x]](StructureDefinition-hiv-e-de264.html)|
|HIV.E.DE3|Pregnant woman's unique ID|Unique identifier generated for new clients or a universal ID, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-e-de3.html)|
|HIV.E.DE35|Other past pregnancy problems (specify)|Woman experienced other past pregnancy problems not described above (specify)|string|[Observation.value[x]](StructureDefinition-hiv-e-de35.html)|
|HIV.E.DE37|Pregnancy in HIV-infected woman|Any HIV diagnosis in a pregnant woman as determined by the national HIV testing algorithm, or a pregnancy in a woman previously diagnosed with HIV|string|[Observation.value[x]](StructureDefinition-hiv-e-de37.html)|
|HIV.E.DE38|Date new pregnancy of HIV-positive woman identified|Earliest date when a new pregnancy of an HIV-positive woman is recorded|string|[Observation.value[x]](StructureDefinition-hiv-e-de38.html)|
|HIV.E.DE39|ANC contact during pregnancy|Whether the mother had at least one ANC contact (visit)|string|[Observation.value[x]](StructureDefinition-hiv-e-de39.html)|
|HIV.E.DE4|Antenatal care number|Identification number assigned to woman at first visit to the ANC based on national system|string|[Observation.value[x]](StructureDefinition-hiv-e-de4.html)|
|HIV.E.DE40|Date of first ANC visit|Date of the pregnant woman's first ANC visit|string|[Observation.value[x]](StructureDefinition-hiv-e-de40.html)|
|HIV.E.DE41|Timing of ART initiation|When the pregnant woman or mother initiated ART, for women living with HIV.|string|[Observation.value[x]](StructureDefinition-hiv-e-de41.html)|
|HIV.E.DE45|Maternal use of recommended ART regimen|Whether the mother is taking a recommended ART regimen|string|[Observation.value[x]](StructureDefinition-hiv-e-de45.html)|
|HIV.E.DE46|Delivery date|Date on which the woman delivered|string|[Observation.value[x]](StructureDefinition-hiv-e-de46.html)|
|HIV.E.DE47|Pregnancy outcome|Outcome of current pregnancy|string|[Observation.value[x]](StructureDefinition-hiv-e-de47.html)|
|HIV.E.DE52|Delivery mode|Mode of delivery for current pregnancy|string|[Observation.value[x]](StructureDefinition-hiv-e-de52.html)|
|HIV.E.DE56|Indications for caesarian section (C/S)|Indications for caesarian section|string|[Observation.value[x]](StructureDefinition-hiv-e-de56.html)|
|HIV.E.DE57|Obstetric complications|Serious or life-threatening obstetric complications during pregnancy, delivery or postpartum experienced by mother or her newborn|string|[Observation.value[x]](StructureDefinition-hiv-e-de57.html)|
|HIV.E.DE58|Live birth|The woman had a live birth|string|[Observation.value[x]](StructureDefinition-hiv-e-de58.html)|
|HIV.E.DE59|Live birth to an HIV-positive woman|A woman living with HIV had a live birth|string|[Observation.value[x]](StructureDefinition-hiv-e-de59.html)|
|HIV.E.DE6|Source of gestational age|Gestational age can be calculated multiple ways. This data element describes where the gestational age above has been calculated from.|string|[Observation.value[x]](StructureDefinition-hiv-e-de6.html)|
|HIV.E.DE60|Gestational age at birth|Best estimate of gestational age in completed weeks when infant was born (an indication of prematurity, preterm and extreme preterm)|string|[Observation.value[x]](StructureDefinition-hiv-e-de60.html)|
|HIV.E.DE61|Small for gestational age (SGA)|Whether the infant was small for gestational age (SGA) at birth (<10th percentile)|string|[Observation.value[x]](StructureDefinition-hiv-e-de61.html)|
|HIV.E.DE62|Preterm birth status|The woman gave birth when the gestational age is less than 37 weeks|string|[Observation.value[x]](StructureDefinition-hiv-e-de62.html)|
|HIV.E.DE66|Maternal ART start date|The date on which the infant was started or restarted on ART|string|[Observation.value[x]](StructureDefinition-hiv-e-de66.html)|
|HIV.E.DE67|Place of delivery|The type of place where the woman delivered|string|[Observation.value[x]](StructureDefinition-hiv-e-de67.html)|
|HIV.E.DE72|Delivery facility|Facility where the infant or child was born|string|[Observation.value[x]](StructureDefinition-hiv-e-de72.html)|
|HIV.E.DE73|Date of miscarriage or abortion|Date of the miscarriage/abortion|string|[Observation.value[x]](StructureDefinition-hiv-e-de73.html)|
|HIV.E.DE74|Date of death of mother|Date that the woman died|string|[Observation.value[x]](StructureDefinition-hiv-e-de74.html)|
|HIV.E.DE75|Cause of death of mother|The woman's cause of death|string|[Observation.value[x]](StructureDefinition-hiv-e-de75.html)|
|HIV.E.DE76|Infant's first name|Infant's first or given name|string|[Observation.value[x]](StructureDefinition-hiv-e-de76.html)|
|HIV.E.DE77|Infant's surname|Infant's family name or last name|string|[Observation.value[x]](StructureDefinition-hiv-e-de77.html)|
|HIV.E.DE78|Infant's unique ID|Unique identifier generated for new clients or a universal ID, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-e-de78.html)|
|HIV.E.DE79|Mother's first name|Biological mother's first or given name|string|[Observation.value[x]](StructureDefinition-hiv-e-de79.html)|
|HIV.E.DE80|Mother's surname|Biological mother's family name or last name|string|[Observation.value[x]](StructureDefinition-hiv-e-de80.html)|
|HIV.E.DE81|Mother's unique ID|Unique identifier generated for new clients or a universal ID, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-e-de81.html)|
|HIV.E.DE82|Caregiver's first name|Caregiver's first or given name|string|[Observation.value[x]](StructureDefinition-hiv-e-de82.html)|
|HIV.E.DE83|Caregiver's surname|Caregiver's family name or last name|string|[Observation.value[x]](StructureDefinition-hiv-e-de83.html)|
|HIV.E.DE84|Caregiver's unique identifier|Unique identifier generated for new clients or a universal ID, if used in the country|string|[Observation.value[x]](StructureDefinition-hiv-e-de84.html)|
|HIV.E.DE85|ANC contact date|The date and time of the client's ANC contact (in the ANC DAK this is called 'Contact date')|string|[Observation.value[x]](StructureDefinition-hiv-e-de85.html)|
|HIV.E.DE87|Infant date of birth|The infant's date of birth (DOB) if known|string|[Observation.value[x]](StructureDefinition-hiv-e-de87.html)|
|HIV.E.DE88|Date of birth of infant unknown|Is the client's DOB unknown?|string|[Observation.value[x]](StructureDefinition-hiv-e-de88.html)|
|HIV.E.DE89|Estimated age of infant|If DOB is unknown, enter the client's estimated age. Display client's age in number of years|string|[Observation.value[x]](StructureDefinition-hiv-e-de89.html)|
|HIV.E.DE90|Age of infant|Infant age calculated using date of birth|string|[Observation.value[x]](StructureDefinition-hiv-e-de90.html)|
|HIV.E.DE91|Gender of infant|Gender of the infant|string|[Observation.value[x]](StructureDefinition-hiv-e-de91.html)|
|HIV.E.DE95|Infant height|The infant's height in centimetres|string|[Observation.value[x]](StructureDefinition-hiv-e-de95.html)|
|HIV.E.DE96|Infant weight|The infant's current weight in kilograms|string|[Observation.value[x]](StructureDefinition-hiv-e-de96.html)|
|HIV.E.DE97|Birth weight|Birth weight in kg of the baby|string|[Observation.value[x]](StructureDefinition-hiv-e-de97.html)|
|HIV.E.DE98|Low birth weight|Note if infant </¬¨‚â•2500 g at birth|string|[Observation.value[x]](StructureDefinition-hiv-e-de98.html)|
|HIV.E.DE99|Length of infant|Length of infant at birth in cm|string|[Observation.value[x]](StructureDefinition-hiv-e-de99.html)|
|HIV.G.DE10|Date viral load sample sent|Date viral load sample sent to the lab|string|[Observation.value[x]](StructureDefinition-hiv-g-de10.html)|
|HIV.G.DE11|First viral load test result|Result from the initial viral load test in number of copies/mL|string|[Observation.value[x]](StructureDefinition-hiv-g-de11.html)|
|HIV.G.DE13|HIV viral load specimen type|The type of specimen to be used to test viral load|string|[Observation.value[x]](StructureDefinition-hiv-g-de13.html)|
|HIV.G.DE22|Reason Hepatitis B test not conducted|Reason why a hepatitis B test was not done|string|[Observation.value[x]](StructureDefinition-hiv-g-de22.html)|
|HIV.G.DE29|Hepatitis B diagnosis|Client's hepatitis B diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-g-de29.html)|
|HIV.G.DE32|Hepatitis C screening date|Date when client was screened for HCV|string|[Observation.value[x]](StructureDefinition-hiv-g-de32.html)|
|HIV.G.DE34|Hepatitis C test conducted|Whether a hepatitis C test was conducted|string|[Observation.value[x]](StructureDefinition-hiv-g-de34.html)|
|HIV.G.DE35|Reason Hepatitis C test not done|Reason why a hepatitis C test was not done|string|[Observation.value[x]](StructureDefinition-hiv-g-de35.html)|
|HIV.G.DE4|Date of baseline CD4 count sample collection|Date and time when baseline CD4 count test sample was collected|string|[Observation.value[x]](StructureDefinition-hiv-g-de4.html)|
|HIV.G.DE51|Hepatitis C diagnosis|Client's hepatitis C diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-g-de51.html)|
|HIV.G.DE6|Date of CD4 sample collection|Date sample to be used for CD4 count was collected|string|[Observation.value[x]](StructureDefinition-hiv-g-de6.html)|
|HIV.G.DE62|Reason syphilis test not done|Reason why a syphilis test was not done|string|[Observation.value[x]](StructureDefinition-hiv-g-de62.html)|
|HIV.G.DE7|Viral load test conducted|A viral load test was performed|string|[Observation.value[x]](StructureDefinition-hiv-g-de7.html)|
|HIV.G.DE74|Syphilis diagnosis|Client's syphilis diagnosis|string|[Observation.value[x]](StructureDefinition-hiv-g-de74.html)|
|HIV.G.DE77|Other tests conducted|If the health worker performed other tests on the woman that are not explicitly listed in the application, select "yes" here and fill in the details below.|string|[Observation.value[x]](StructureDefinition-hiv-g-de77.html)|
|HIV.G.DE78|Other test(s) name|Input the name of other test(s) that were done.|string|[Observation.value[x]](StructureDefinition-hiv-g-de78.html)|
|HIV.G.DE79|Other test(s) date|Input the date of other test(s) that were done.|string|[Observation.value[x]](StructureDefinition-hiv-g-de79.html)|
|HIV.G.DE80|Other test(s) result(s)|Input the result from the test(s).|string|[Observation.value[x]](StructureDefinition-hiv-g-de80.html)|
|HIV.G.DE9|Date of first viral load sample collection|Date and time when the sample was collected to test the client's HIV viral load for the first time|string|[Observation.value[x]](StructureDefinition-hiv-g-de9.html)|
|HIV.H.DE1|Reason for follow-up|The reason why the client is being followed up|string|[Observation.value[x]](StructureDefinition-hiv-h-de1.html)|
|HIV.H.DE10|Client contact attempted|An attempt to locate the client was made|string|[Observation.value[x]](StructureDefinition-hiv-h-de10.html)|
|HIV.H.DE11|Date of contact attempt|Date of attempt to contact client|string|[Observation.value[x]](StructureDefinition-hiv-h-de11.html)|
|HIV.H.DE12|Contact attempted by|Who attempted to reach out to the client|string|[Observation.value[x]](StructureDefinition-hiv-h-de12.html)|
|HIV.H.DE13|Contact method|Method used to try to reach out to the client|string|[Observation.value[x]](StructureDefinition-hiv-h-de13.html)|
|HIV.H.DE17|Source of information|Source of information about the client|string|[Observation.value[x]](StructureDefinition-hiv-h-de17.html)|
|HIV.H.DE22|Other source of information (specify)|Information about the client's status was provided by someone else (specify)|string|[Observation.value[x]](StructureDefinition-hiv-h-de22.html)|
|HIV.H.DE23|Outcome from outreach attempt|Detailed outcome from the attempt to locate the client|string|[Observation.value[x]](StructureDefinition-hiv-h-de23.html)|
|HIV.H.DE30|Moved from catchment area|The client moved from the catchment area (may be reported from the community level)|string|[Observation.value[x]](StructureDefinition-hiv-h-de30.html)|
|HIV.H.DE31|Date client moved from catchment area|The date on which the client moved from the catchment area, if known|string|[Observation.value[x]](StructureDefinition-hiv-h-de31.html)|
|HIV.H.DE32|New catchment area|New catchment area where the client resides|string|[Observation.value[x]](StructureDefinition-hiv-h-de32.html)|
|HIV.H.DE33|Partner or contact of index case|The client was identified by an index case as a partner or contact|string|[Observation.value[x]](StructureDefinition-hiv-h-de33.html)|
|HIV.H.DE34|HIV status of partner or contact|HIV status of the partner or contact given by the index case|string|[Observation.value[x]](StructureDefinition-hiv-h-de34.html)|
|HIV.H.DE39|Cause of death|Cause of death, if known|string|[Observation.value[x]](StructureDefinition-hiv-h-de39.html)|
|HIV.H.DE40|Place of death|Where the client died, if known|string|[Observation.value[x]](StructureDefinition-hiv-h-de40.html)|
|HIV.H.DE41|HIV treatment outcome|The outcome for the client which is used for reporting retention/attrition.|string|[Observation.value[x]](StructureDefinition-hiv-h-de41.html)|
|HIV.H.DE46|Date patient lost to follow-up|Date patient was lost to follow-up (LTFU)|string|[Observation.value[x]](StructureDefinition-hiv-h-de46.html)|
|HIV.H.DE48|Date HIV treatment outcome changed|The date on which the client's outcome (lost to follow-up, transferred out, death (documented), or refused (stopped) treatment) changed|string|[Observation.value[x]](StructureDefinition-hiv-h-de48.html)|
|HIV.H.DE49|Transfer confirmed|Select if transfer to another facility is confirmed|string|[Observation.value[x]](StructureDefinition-hiv-h-de49.html)|
|HIV.H.DE50|Transfer to facility|Name of health facility client was transferred to|string|[Observation.value[x]](StructureDefinition-hiv-h-de50.html)|
|HIV.H.DE51|Date of transfer out|The date the client transferred out of the facility to be provided with care at another facility|string|[Observation.value[x]](StructureDefinition-hiv-h-de51.html)|
|HIV.H.DE52|Adherence assessment|Whether client is adherent or not to ART regimen per national guidelines (immunological or virological monitoring)|string|[Observation.value[x]](StructureDefinition-hiv-h-de52.html)|
|HIV.H.DE9|Other follow-up reason (specify)|Client was followed up for another reason (specify)|string|[Observation.value[x]](StructureDefinition-hiv-h-de9.html)|
|HIV.I.DE1|Emergency referral|Referral for urgent care|string|[Observation.value[x]](StructureDefinition-hiv-i-de1.html)|
|HIV.I.DE10|Date of scheduled referral appointment|When the referral is scheduled|string|[Observation.value[x]](StructureDefinition-hiv-i-de10.html)|
|HIV.I.DE11|Location of scheduled referral appointment|Where the client is being referred to|string|[Observation.value[x]](StructureDefinition-hiv-i-de11.html)|
|HIV.I.DE12|Date referral was made|The date the referral was made|string|[Observation.value[x]](StructureDefinition-hiv-i-de12.html)|
|HIV.I.DE13|Provider who made referral|The name of the provider who made the referral|string|[Observation.value[x]](StructureDefinition-hiv-i-de13.html)|
|HIV.I.DE14|Provider's facility|Facility client is being referred from|string|[Observation.value[x]](StructureDefinition-hiv-i-de14.html)|
|HIV.I.DE15|Provider's telephone number|The contact details of the provider making the referral|string|[Observation.value[x]](StructureDefinition-hiv-i-de15.html)|
|HIV.I.DE16|Referral notes|Any additional relevant details of clinical significance for the referral facility to provide quality care|string|[Observation.value[x]](StructureDefinition-hiv-i-de16.html)|
|HIV.I.DE17|Client history summary|With interoperable systems, the provider receiving the referral should be able to access the client's health record digitally. However, in the absence of this, the referral provider should receive a summary of the client's health records that includes the client's history, medications, medications prescribed or dispensed, reported issues and concerns, and any other relevant clinical information the health care provider had already obtained.|string|[Observation.value[x]](StructureDefinition-hiv-i-de17.html)|
|HIV.I.DE2|Reason for referral|Reason why the client is being referred. If diagnosed, this may include the reason for the diagnosis.|string|[Observation.value[x]](StructureDefinition-hiv-i-de2.html)|
|HIV.I.DE8|Referral for other general services (specify)|If none of the reasons above apply, specify the reason(s)|string|[Observation.value[x]](StructureDefinition-hiv-i-de8.html)|
|HIV.I.DE9|Any treatment given before referral|If client was referred, was any treatment provided before referral?|string|[Observation.value[x]](StructureDefinition-hiv-i-de9.html)|
|HIV.PRV.DE10|Date accessed HIV prevention intervention|Date the client accessed HIV prevention intervention|string|[Observation.value[x]](StructureDefinition-hiv-prv-de10.html)|
|HIV.PRV.DE11|HIV status of contact|The HIV status of the client's contact|string|[Observation.value[x]](StructureDefinition-hiv-prv-de11.html)|
|HIV.PRV.DE15|Date injecting equipment provided|Date client was provided with injecting equipment|string|[Observation.value[x]](StructureDefinition-hiv-prv-de15.html)|
|HIV.PRV.DE16|Number of needles-syringes provided|Number of needles-syringes provided to client|string|[Observation.value[x]](StructureDefinition-hiv-prv-de16.html)|
|HIV.PRV.DE17|Date OAMT initiated|Date client initiated opioid agonist maintenance treatment (OAMT)|string|[Observation.value[x]](StructureDefinition-hiv-prv-de17.html)|
|HIV.PRV.DE18|Date OAMT dose received|Date client received opioid agonist maintenance treatment (OAMT) dose|string|[Observation.value[x]](StructureDefinition-hiv-prv-de18.html)|
|HIV.PRV.DE19|Date OAMT take-away dose(s) dispensed|Date the client was dispensed opioid agonist maintenance treatment (OAMT) take-away dose(s)|string|[Observation.value[x]](StructureDefinition-hiv-prv-de19.html)|
|HIV.PRV.DE2|HIV prevention intervention|HIV prevention intervention that client accessed|string|[Observation.value[x]](StructureDefinition-hiv-prv-de2.html)|
|HIV.PRV.DE20|Currently on OAMT|Client is currently on opioid agonist maintenance treatment (OAMT) at reporting date, defined according to country/program to account for medication dispensed and LTFU criterion|string|[Observation.value[x]](StructureDefinition-hiv-prv-de20.html)|
|HIV.PRV.DE21|Retained on OAMT|Client is retained on opioid agonist maintenance treatment (OAMT) at reporting date, defined according to country/program to account for medication dispensed and LTFU criterion|string|[Observation.value[x]](StructureDefinition-hiv-prv-de21.html)|
|HIV.PRV.DE22|Client being inducted on OAMT|Client is currently being inducted on opioid agonist maintenance treatment (OAMT), defined according to country/program|string|[Observation.value[x]](StructureDefinition-hiv-prv-de22.html)|
|HIV.PRV.DE23|Client on reducing doses of OAMT|Client is current on reducing doses of opioid agonist maintenance treatment (OAMT), defined according to country/program|string|[Observation.value[x]](StructureDefinition-hiv-prv-de23.html)|
|HIV.PRV.DE24|Date first maintenance dose received|First date on which client received maintenance dose|string|[Observation.value[x]](StructureDefinition-hiv-prv-de24.html)|
|HIV.PRV.DE25|Date of loss to follow-up or OAMT stopped|Date of loss to follow-up or opioid agonist maintenance treatment (OAMT) stopped|string|[Observation.value[x]](StructureDefinition-hiv-prv-de25.html)|
